
<html lang="en"     class="pb-page"  data-request-id="10a4eabf-5afc-46a8-8eca-bc1955c71ab6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c00475;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation" /></meta><meta name="dc.Creator" content="Robert  Peery" /></meta><meta name="dc.Creator" content="Kwaku  Kyei-Baffour" /></meta><meta name="dc.Creator" content="Zizheng  Dong" /></meta><meta name="dc.Creator" content="Jianguo  Liu" /></meta><meta name="dc.Creator" content="Pedro  de Andrade&#xA;Horn" /></meta><meta name="dc.Creator" content="Mingji  Dai" /></meta><meta name="dc.Creator" content="Jing-Yuan  Liu" /></meta><meta name="dc.Creator" content="Jian-Ting  Zhang" /></meta><meta name="dc.Description" content="Survivin, a homodimeric member of the Inhibitor of Apoptosis Protein (IAP) family, is required for cancer cell survival and overexpressed in almost all solid tumors. However, targeting survivin has..." /></meta><meta name="Description" content="Survivin, a homodimeric member of the Inhibitor of Apoptosis Protein (IAP) family, is required for cancer cell survival and overexpressed in almost all solid tumors. However, targeting survivin has..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00475" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00475" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00475" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00475" /></link>
        
    
    

<title>Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00475" /></meta><meta property="og:title" content="Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0008.jpeg" /></meta><meta property="og:description" content="Survivin, a homodimeric member of the Inhibitor of Apoptosis Protein (IAP) family, is required for cancer cell survival and overexpressed in almost all solid tumors. However, targeting survivin has been challenging due to its “undruggable” nature. Recently, we used a novel approach to target the dimerization interface and identified inhibitors of two scaffolds that can directly bind to and inhibit survivin dimerization. One of the scaffolds, represented by the compound LQZ-7, contains an undesirable labile hydrazone linker and a potentially nonfunctional furazanopyrazine ring that we attempted to eliminate in this study. We found one compound, 7I, that is more active than the parent compound, LQZ-7, and when given orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors. These findings indicate that 7I with a stable linker and a quinoxaline ring can be used as a lead for further optimization of this novel class of survivin inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00475"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00475">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00475&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00475&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00475&amp;href=/doi/10.1021/acs.jmedchem.0c00475" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 7243-7251</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00464" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00479" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Robert Peery</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Peery</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Peery">Robert Peery</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwaku Kyei-Baffour</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwaku Kyei-Baffour</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwaku++Kyei-Baffour">Kwaku Kyei-Baffour</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zizheng Dong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zizheng Dong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States</div><div class="loa-info-affiliations-info">Department of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zizheng++Dong">Zizheng Dong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jianguo Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianguo Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianguo++Liu">Jianguo Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pedro de Andrade Horn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pedro de Andrade Horn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pedro++de+Andrade%0AHorn">Pedro de Andrade Horn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mingji Dai</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mingji Dai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (765) 496-7898. E-mail: <a href="/cdn-cgi/l/email-protection#b4d9ded0d5ddf4c4c1c6d0c1d19ad1d0c1"><span class="__cf_email__" data-cfemail="c8a5a2aca9a188b8bdbaacbdade6adacbd">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mingji++Dai">Mingji Dai</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7956-6426" title="Orcid link">http://orcid.org/0000-0001-7956-6426</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing-Yuan Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing-Yuan Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States</div><div class="loa-info-affiliations-info">Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (419) 383-4149. Email: <a href="/cdn-cgi/l/email-protection#bbd1d2d5dcc2cedad595d7d2cefbcecfd4d7dedfd495dedfce"><span class="__cf_email__" data-cfemail="bbd1d2d5dcc2cedad595d7d2cefbcecfd4d7dedfd495dedfce">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing-Yuan++Liu">Jing-Yuan Liu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jian-Ting Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian-Ting Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States</div><div class="loa-info-affiliations-info">Department of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (419) 383-4131. Email: <a href="/cdn-cgi/l/email-protection#2b41424a455f42454c0551434a454c6b5e5f44474e4f44054e4f5e"><span class="__cf_email__" data-cfemail="553f3c343b213c3b327b2f3d343b321520213a3930313a7b303120">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian-Ting++Zhang">Jian-Ting Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2803-9914" title="Orcid link">http://orcid.org/0000-0002-2803-9914</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00475&amp;href=/doi/10.1021%2Facs.jmedchem.0c00475" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 7243–7251</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 March 2020</li><li><span class="item_label"><b>Published</b> online</span>18 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00475" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00475</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7243%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BPeery%252C%2BKwaku%2BKyei-Baffour%252C%2BZizheng%2BDong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D13%26contentID%3Dacs.jmedchem.0c00475%26title%3DSynthesis%2Band%2BIdentification%2Bof%2Ba%2BNovel%2BLead%2BTargeting%2BSurvivin%2BDimerization%2Bfor%2BProteasome-Dependent%2BDegradation%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7251%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00475"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1001</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00475" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Peery&quot;},{&quot;first_name&quot;:&quot;Kwaku&quot;,&quot;last_name&quot;:&quot;Kyei-Baffour&quot;},{&quot;first_name&quot;:&quot;Zizheng&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Jianguo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Pedro&quot;,&quot;last_name&quot;:&quot;de Andrade\nHorn&quot;},{&quot;first_name&quot;:&quot;Mingji&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Jing-Yuan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jian-Ting&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7243-7251&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00475&quot;},&quot;abstract&quot;:&quot;Survivin, a homodimeric member of the Inhibitor of Apoptosis Protein (IAP) family, is required for cancer cell survival and overexpressed in almost all solid tumors. However, targeting survivin has been challenging due to its “undruggable” nature. Recently, we used a novel approach to target the dimerization interface and identified inhibitors of two scaffolds that can directly bind to and inhibit survivin dimerization. One of the scaffolds, represented by the compound LQZ-7, contains an undesirable labile hydrazone linker and a potentially nonfunctional furazanopyrazine ring that we attempted to eliminate in this study. We found one compound, 7I, that is more active than the parent compound, LQZ-7, and when given orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors. These findings indicate that 7I with a stable linker and a quinoxaline ring can be used as a lead for further optimization of this novel class of survivin inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00475&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00475" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00475&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00475" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00475&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00475" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00475&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00475&amp;href=/doi/10.1021/acs.jmedchem.0c00475" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00475" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00475" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00475%26sid%3Dliteratum%253Aachs%26pmid%3D32421328%26genre%3Darticle%26aulast%3DPeery%26date%3D2020%26atitle%3DSynthesis%2Band%2BIdentification%2Bof%2Ba%2BNovel%2BLead%2BTargeting%2BSurvivin%2BDimerization%2Bfor%2BProteasome-Dependent%2BDegradation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D7243%26epage%3D7251%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290899" title="Dimerization">Dimerization</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Survivin, a homodimeric member of the Inhibitor of Apoptosis Protein (IAP) family, is required for cancer cell survival and overexpressed in almost all solid tumors. However, targeting survivin has been challenging due to its “undruggable” nature. Recently, we used a novel approach to target the dimerization interface and identified inhibitors of two scaffolds that can directly bind to and inhibit survivin dimerization. One of the scaffolds, represented by the compound LQZ-7, contains an undesirable labile hydrazone linker and a potentially nonfunctional furazanopyrazine ring that we attempted to eliminate in this study. We found one compound, <b>7I</b>, that is more active than the parent compound, LQZ-7, and when given orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors. These findings indicate that <b>7I</b> with a stable linker and a quinoxaline ring can be used as a lead for further optimization of this novel class of survivin inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Survivin (BIRC5), a 16.5 kDa homodimeric protein,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> is a member of the Inhibitor of Apoptosis Protein (IAP) family with a single BIR domain, a zinc-finger fold, and an extended C-terminal helical coiled coil.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> Ectopic overexpression of survivin inhibits both intrinsic and extrinsic apoptosis pathways in cell lines and animal models and has been suggested to contribute to treatment resistance.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Interestingly, survivin is expressed at undetectable or low levels in normal adult tissues, while it has been shown to be overexpressed in almost all solid tumors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Molecular probes such as antisense oligonucleotides, ribozymes, siRNAs, and dominant negative mutants all resulted in caspase-dependent cell death and increased drug-induced apoptosis.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16">(10−16)</a> Thus, survivin has become a significant and attractive drug target.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">However, survivin has been considered “undruggable” due to lack of known enzymatic activities, and the majority of drug discovery studies targeting survivin have avoided targeting the protein directly.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Recently, using a combination of computational analysis and <i>in silico</i> screening, we have identified the first direct small molecule inhibitor of survivin targeting the residues Leu98 and Phe101 in the dimerization interface of survivin to inhibit survivin dimerization.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The initial hit inhibitor, LQZ-7, upon binding to the survivin dimeric interface, causes exposure of the hydrophobic dimerization core and leads to protein misfolding and subsequent degradation in the proteasome.</div><div class="NLM_p last">In the current study, we further investigated the scaffold of LQZ-7 and synthesized five novel analogues with a goal to improve its properties and assess whether removal of the undesirable labile hydrazone linker and a potentially nonfunctional furazanopyrazine is possible. Of these 5 analogues, one compound LQZ-7I (<b>7I</b>), showed significantly improved activity and is the focus of this work. The data obtained utilizing <b>7I</b> in both <i>in vitro</i> and <i>in vivo</i> studies highlights its potential as a lead for further development, which may yield a potential cancer therapeutic by targeting the survivin protein directly.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of Novel LQZ-7 Analogues</h3><div class="NLM_p">To investigate the structure–activity relationship of LQZ-7 for lead identification and creation of better and novel survivin inhibitors, we first performed molecular dynamic simulation analysis of LQZ-7 bound to the dimeric interface of survivin. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B, LQZ-7 has three important interactions with survivin: (a) a H-bond between an aniline NH group of LQZ-7 and Glu94 of survivin; (b) an interaction between the substituted aniline in LQZ-7 and Phe93, Phe101, and Leu98 in the hydrophobic pocket of survivin via π–π stacking and hydrophobic interactions; and (c) a H-bond between the carboxylic acid of LQZ-7 and Trp10 of survivin. This analysis shows clearly that the furazanopyrazine ring did not contribute to the binding to survivin. It is also noteworthy that LQZ-7 has a labile hydrazone linker, which is undesirable. Thus, for the new synthesis, we attempted to remove the hydrazone linker and to replace the furazanopyrazine with a quinoxaline ring. To this end, five analogues were synthesized by two nucleophilic aromatic substitutions of dichloroquinoxaline with the corresponding amine or amide nucleophiles (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). All five analogues, LQZ-7G to LQZ-7K (<b>7G</b>–<b>7K</b>), retain the two predicted critical interactions with survivin and have the labile hydrazone linker replaced.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Analysis of LQZ-7 binding to survivin and synthesis of LQZ-7 analogues. (A) Molecular dynamic simulation analysis of LQZ-7 bound to the dimeric interface of survivin. (B) Critical interactions between LQZ-7 and survivin. (C) Scheme of LQZ-7 analogue (quinoxaline derivatives) synthesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Compound <b>7I</b> Has Enhanced Cytotoxicity Compared to the Parent Compound LQZ-7</h3><div class="NLM_p">These five newly synthesized LQZ-7 analogs were first tested for their cytotoxicity against prostate cancer cell lines C4-2 and PC-3 in comparison with their parent compound LQZ-7 using methylene blue assay. Dose–response survival curves were generated following 72 h treatments (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S1</a>), which were used to derive their IC<sub>50</sub> values. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B, the analogue <b>7I</b> has improved cytotoxicity with an IC<sub>50</sub> of 3.1 μM against C4-2 cells and 4.8 μM against PC-3 cells compared with the parent compound LQZ-7, which has IC<sub>50</sub> values of 9.1 and 8.1 μM, respectively. The other compounds performed worse with higher IC<sub>50</sub> values compared with LQZ-7.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Characterization of LQZ-7 analogues. (A, B) IC<sub>50</sub> of LQZ-7 and its analogues in C4-2 (A) and PC-3 (B) cells derived from dose–response survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S1</a>) as determined using methylene blue assay. (C, D) SEAP reporter activity determined using mammalian two hybrid assay in the presence of LQZ-7 or its analogues. Vector and p53/large T antigen were used as negative and positive controls for the assay, respectively (*<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Compound <b>7I</b> Inhibits Survivin Dimerization</h3><div class="NLM_p">As this series of survivin inhibitors were designed to exert their action through interaction with the dimeric interface and disruption of survivin dimerization, we next assessed their activity in inhibiting survivin dimerization using a mammalian two hybrid assay by fusing one survivin molecule to the GAL4-DNA-binding domain and another to the VP16 activation domain. Dimerization of survivin activates the expression of the secreted embryonic alkaline phosphatase (SEAP) reporter gene, which can be monitored. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, <b>7I</b> significantly decreased the SEAP reporter expression, while <b>7H</b> slightly inhibited and the other compounds did not reduce reporter expression, consistent with their limited cytotoxicity against C4-2 and PC-3 cells. Thus, <b>7I</b> was chosen for further studies.</div><div class="NLM_p last">To ensure that the <b>7I</b> inhibition of survivin dimerization in the above two hybrid assay is specific to survivin and to eliminate any potential nonspecific effect, we tested the effect of newly synthesized <b>7I</b> on the dimerization of p53 with the large T antigen using the same mammalian two-hybrid assay and including the vector control. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D, both <b>7I</b> and the parent compound LQZ-7 significantly inhibited survivin dimerization. However, they had no effect on p53–large T antigen dimerization or the basal reporter expression from vector alone, suggesting that the <b>7I</b> inhibition of survivin dimerization may be specific. Furthermore, <b>7I</b> is significantly more effective than LQZ-7 in inhibiting survivin dimerization, consistent with the difference in their IC<sub>50</sub> values against different prostate cancer cell lines. These findings also suggest that <b>7I</b> may inhibit cell survival via inhibiting survivin dimerization.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Survivin Expression Level Correlates with <b>7I</b> IC<sub>50</sub> in Different Prostate Cancer Cell Lines</h3><div class="NLM_p">To determine if <b>7I</b> inhibits cell survival via inhibiting survivin, we performed an association analysis of survivin expression with <b>7I</b> IC<sub>50</sub> in five prostate cancer cell lines. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A shows the relative survivin level in five prostate cancer cell lines assessed using Western blot analyses. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B shows the IC<sub>50</sub> of <b>7I</b> in these cell lines derived from dose-dependent survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S2</a>). Association analysis showed that the IC<sub>50</sub> of <b>7I</b> strongly correlates with the survivin expression level with a correlation coefficient <i>R</i><sup>2</sup> = 0.79 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). This finding suggests that the cancer cells with higher level of survivin expression are more resistant to <b>7I</b> and that <b>7I</b> likely exerts its cytotoxicity via survivin.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Relative survivin protein level in different human prostate cancer cell lines determined using Western blot analyses. (B) IC<sub>50</sub> of <b>7I</b> in different human prostate cancer cell lines derived from dose-dependent survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S2</a>) as determined using methylene blue assay. (C) Association of <b>7I</b> IC<sub>50</sub> with survivin expression level in different human prostate cancer cell lines. (D, E) Expression of HA-tagged survivin determined using Western blot analysis (D) and IC<sub>50</sub> of <b>7I</b> derived from survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S3</a>) as determined using methylene blue assay (E) in stable C4-2 clone with overexpression of HA-tagged survivin (Sur) and vector-transfected (Vec) control cells. (***<i>p</i> < 0.001). (F) Effect of <b>7I</b> on the expression of survivin, XIAP, CIAP1, and CIAP2 in C4-2 and PC-3 cells as determined using Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Survivin Overexpression Decreases Cellular Sensitivity to <b>7I</b></h3><div class="NLM_p last">To corroborate the above findings and to further investigate if <b>7I</b> inhibition of cancer cell survival is via survivin, we generated a stable C4-2 clone with overexpression of HA-tagged survivin (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) and tested the effect of survivin overexpression on <b>7I</b> cytotoxicity. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S3</a>, survivin overexpression significantly increased cellular resistance to <b>7I</b> with an IC<sub>50</sub> of ∼7 μM compared with ∼2 μM in vector-transfected control clone, further supporting the conclusion that <b>7I</b> likely works via inhibiting survivin.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Selectivity of <b>7I</b></h3><div class="NLM_p last">As discussed above, <b>7I</b> may selectively inhibit survivin dimerization. To ensure that <b>7I</b> is selective to survivin, we tested <b>7I</b>’s effect on other members of the IAP family by taking advantage of its induction of target loss (see below). For this purpose, we performed Western blot analysis to determine the expression level of other IAPs including XIAP, CIAP1, and CIAP2 in addition to survivin following <b>7I</b> treatment in C4-2 and PC-3 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F, <b>7I</b> treatment reduced the expression of survivin. However, it did not reduce the expression of XIAP, CIAP1, and CIAP2. Thus, <b>7I</b> may be selective to its intended target, survivin.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>7I</b> Induces Survivin Degradation in a Proteasome-Dependent Manner</h3><div class="NLM_p">Previously, it has been shown that the parent compound LQZ-7 induces survivin degradation via a proteasome-dependent mechanism by inhibiting survivin dimerization. Because <b>7I</b> inhibited survivin dimerization as shown above, we hypothesized that <b>7I</b> will also induce survivin degradation. To test this hypothesis, we examined survivin expression level in C4-2 and PC-3 cells following <b>7I</b> treatments. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, <b>7I</b> treatments induced time-dependent survivin loss in both cell lines. We next performed a cycloheximide-chase experiment following <b>7I</b> treatment to determine the half-life of survivin. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,C, <b>7I</b> treatments reduced the half-life of survivin from 2.2 and 2.3 h to 50 and 25 min in C4-2 and PC-3 cells, respectively. Thus, <b>7I</b> induces survivin degradation in both cell lines.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>7I</b> induces survivin degradation in the proteasome. (A) Time course of <b>7I</b>-induced survivin loss in C4-2 and PC-3 cell lines determined using Western blot analysis. (B, C) Effect of <b>7I</b> on survivin half-life. C4-2 and PC-3 cells were pretreated with cycloheximide (CHX) followed by chasing for different times in the presence of <b>7I</b> or DMSO control. Cells were lysed for Western blot analysis of remaining survivin (B) and quantification of gel densities from three independent experiments (C). (D) Effect of proteasome inhibitors MG132 and bortezomib on <b>7I</b>-induced survivin degradation as determined using Western blot analysis. Actin was used as a loading control. Quantification was from three independent experiments (**<i>p</i> < 0.01; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To determine if <b>7I</b>-induced survivin degradation occurs via the proteasome, we performed a rescue experiment by pretreating cells using proteasome inhibitors MG132 and bortezomib for 1 h prior to <b>7I</b> treatment. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, both MG132 and bortezomib significantly reversed <b>7I</b>-induced survivin loss. Thus, <b>7I</b> likely induces survivin degradation via the proteasome.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>7I</b> Induces Apoptosis</h3><div class="NLM_p">As discussed above, depleting survivin or inhibiting survivin using dominant negative forms of survivin cause spontaneous apoptosis in cancer cells, and the parent compound LQZ-7 also induces apoptosis.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We, thus, tested if <b>7I</b> would induce apoptosis by inhibiting survivin. For this purpose, we first performed Western blot analysis of cleaved caspase 3 in C4-2 and PC-3 cells following <b>7I</b> treatments. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B, <b>7I</b> induced cleavage of caspase 3 in a dose dependent manner in both cell lines. We also performed annexin V staining of C4-2 and PC-3 cells as another indicator of apoptosis following <b>7I</b> treatments. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C, 3 μM <b>7I</b> induced ∼48% and ∼39% apoptosis in C4-2 and PC-3 cells, respectively.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>7I</b> induction of apoptosis. (A, B) Western blot analysis of cleaved caspase 3 in C4-2 (A) and PC-3 (B) cells following <b>7I</b> treatment. Quantifications were from three independent experiments. (C) Compound <b>7I</b>-induced apoptosis as determined using Annexin V staining in C4-2 and PC-3 cells (*<i>p</i> < 0.05; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>7I</b> Inhibits Growth of PC-3 Xenograft Tumors by Inhibiting Survivin</h3><div class="NLM_p">We finally determined <b>7I</b>’s <i>in vivo</i> target inhibition and if it is active in suppressing tumor growth using a PC-3 xenograft model. For <i>in vivo</i> analysis, <b>7I</b> was dissolved in corn oil for oral administration. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, <b>7I</b> treatment at 100 mg/kg significantly suppressed tumor growth without any notable adverse effect on the mice as indicated by lacking changes in body weight (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) or in wet weight of major organs at the end of the study (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S4</a>). The xenograft tumors in the <b>7I</b>-teatment group tended to be smaller and paler in color than those of the control group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). Thus, <b>7I</b> may be effective in inhibiting tumor growth with little toxicity.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>7I</b><i>in vivo</i> efficacy and target inhibition. (A, B) Effect of <b>7I</b> on ectopic xenograft tumor growth and body weight in male NSG mice. (■) <b>7I</b>; (●) vehicle. (C) Gross anatomy of xenograft tumors. (D) Final wet weight of xenograft tumors. (E, F) Western blot analysis of <i>in vivo</i> survivin target inhibition by <b>7I</b> treatment. (G) Immunofluorescence staining of survivin in xenograft tumors (*<i>p</i> < 0.05; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We finally examined if <b>7I</b> inhibits the survivin target <i>in vivo</i> in the treatment group by performing Western blot and immunofluorescence staining analyses of xenograft tumors. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E–G, survivin expression was drastically reduced in the xenograft tumors of the treatment group compared with that of the control group. These findings suggest that <b>7I</b> inhibits xenograft tumor growth possibly by inhibiting survivin dimerization and inducing survivin degradation.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we synthesized five analogues of LQZ-7 to investigate the possibility of eliminating the labile hydrazone and replacing the furazanopyrazine with a quinoxaline, resulting in an analogue, <b>7I</b>, that is more active than the parent compound LQZ-7 and soluble in corn oil. Compound <b>7I</b> is also selective to survivin and induces apoptosis and survivin degradation in a proteasome-dependent manner. As a result, <b>7I</b> inhibits cancer cell survival and suppresses xenograft tumor growth.</div><div class="NLM_p">Of the 5 newly synthesized analogues, only <b>7I</b> shows better activity in inducing survivin loss and inhibiting cancer cell survival compared with the parent compound LQZ-7. We presented several lines of evidence that strongly support the conclusion that <b>7I</b> selectively inhibits survivin by inducing survivin loss, leading to inhibition of cancer cell survival, and induction of apoptosis. Thus, <b>7I</b> is unlikely to exert its actions as a potential PAINS molecule. These findings also confirmed our previous observation on LQZ-7 in inducing survivin degradation by potentially binding to the dimeric interface of survivin.</div><div class="NLM_p">Although the other 4 analogues have similar structure to <b>7I</b>, they do not have activity in inhibiting survivin dimerization. Their IC<sub>50</sub> values against prostate cancer cell lines are also high, consistent with their lack of survivin inhibition. In our previous study, several commercially available analogues of LQZ-7 (LQZ-7A–E) have also been studied with variable activities in inducing survivin degradation and in inhibiting cancer cell survival<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It is noteworthy that LQZ-7E (<b>7E</b>) is the only compound that does not have the benzene ring, which is essential for the π–π interaction with survivin, and it displayed a complete loss of the ability to induce survivin degradation and inhibited cancer cell survival with an IC<sub>50</sub> of 60 μM. The other analogues had variable activities in inducing survivin degradation and in inhibiting cancer cell survival.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Characteristics of LQZ-7 Series of Survivin-Targeting Inhibitors<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0007.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The data for LQZ-7A–E were from the previous study.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The IC<sub>50</sub> was determined using MTT assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The data for LQZ-7G–K were from this study. The IC<sub>50</sub> was determined using methylene blue assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ND = not determined.</p></div></div><div></div></div><div class="NLM_p">While we do not have enough information to dissect a detailed structure–activity relationship of these compounds, we feel that with the data obtained in this set of experiments we have accomplished the goal of this study, which was to eliminate the undesirable labile hydrazone linker and potentially nonfunctional furazanopyrazine ring. Indeed, the activity of <b>7I</b> suggests that the labile hydrazone linker and the furazanopyrazine ring of LQZ-7 are replaceable. This study will serve as a proof-of-concept study for future studies continuing to modify <b>7I</b> without the labile hydrazone linker and furazanopyrazine ring, which may lead to identification of more potent compounds. One of the potential modification sites includes the nitrogen linker predicted to interact with Glu94 of survivin. Converting the nitrogen to oxygen may help reveal if the hydrogen bonding is important for <b>7I</b>–survivin interaction. The benzene ring predicted to interact with survivin via π–π stacking is another potential site for further study. We are currently working toward this direction.</div><div class="NLM_p">Because survivin has been shown to contribute to drug resistance by inhibiting drug-induced apoptosis.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a>, it will be of interest to assess the effectiveness of <b>7I</b> in combination with chemotherapy for synergism in further suppression of xenograft tumor growth greater than <b>7I</b> treatment alone. One possible combination for the castration resistant prostate cancer is docetaxel, which is a frontline treatment for this disease. Although very challenging, it will also be of interest to investigate the binding affinity of <b>7I</b> versus survivin dimerization affinity and to investigate if <b>7I</b> inhibits survivin dimerization on or off rate.</div><div class="NLM_p">Future studies are also warranted to explore the complex upstream regulatory pathways that tightly control survivin expression to assess the effectiveness of our inhibitors for cancer cells with different genetic backgrounds. For example, we note a trend that <b>7I</b> cytotoxicity correlates with p53 status in the five different prostate cancer cells lines. The cell lines with mutant p53 or p53 null (PC-3 and DU-145) tend to not only have higher survivin expression as one would expect but also higher <b>7I</b> IC<sub>50</sub>. C4-2 and LNCaP with functional p53 had lower survivin protein levels and lower <b>7I</b> IC<sub>50</sub>. Interestingly, 22RV-1 cells, which are known to have both full and truncated versions of p53, behave similarly to the cells with mutant p53 in this study. Although DNA-damaging agents are not the standard of care for castration resistant prostate cancers, information like this may help guide us in what context and disease state these survivin inhibitors may be most effective. Other upstream regulators of survivin, such as STAT3 and NF-κB, and their potential relationship with the cytotoxicity of our survivin dimerization inhibitors may also need to be investigated.</div><div class="NLM_p">It is also noteworthy that although castration resistant prostate cancer was the disease focus of this study, survivin inhibitors may be also developed against other difficult-to-treat cancers such as glioblastoma since survivin expression is up-regulated in essentially all solid tumors. It is our long-term goal to expand and apply our knowledge in developing this class of unique survivin inhibitors to test their effectiveness in other difficult-to-treat cancers.</div><div class="NLM_p">In a previous publication,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we detailed the discovery of another LQZ-7 analogue, LQZ-7F (<b>7F</b>). The interesting feature of <b>7F</b> compared to LQZ-7 and <b>7I</b> is that it was the only compound identified in any of our screenings that had a different backbone scaffold. This compound displayed a locked backbone conformation consisting of 2 five-membered rings and 2 six-membered rings that maintained key interactions with survivin including (a) and H-bond between the primary amine group of 7F and Glu94 of survivin and (b) π–π stacking and hydrophobic interactions between the tetracyclic furazanopyrazine ring of <b>7F</b> and the hydrophobic residues Trp10 and Phe93 in addition to the dimerization core residues Leu98 and Phe101. Compound <b>7F</b> displayed more potent inhibition of cancer cells and had a strong positive correlation between survivin expression and cytotoxicity in cancer cell lines. More importantly, in an <i>in vivo</i> xenograft model, <b>7F</b> treatment via ip injection significantly inhibited the growth of xenograft tumors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p last">In conclusion, there are two structural scaffolds of inhibitors targeting the dimerization interface of survivin, represented by <b>7F</b> and <b>7I</b>, which effectively inhibit survivin dimerization, induce survivin degradation in the proteasome, and induce apoptosis of prostate cancer cells. They both also effectively inhibit xenograft tumor growth and reduce survivin level <i>in vivo</i>. Thus, both <b>7F</b> and <b>7I</b> can be used as leads of different scaffolds for further optimization.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Materials</h3><div class="NLM_p last">Antibodies against HA tag (H6908) and actin (A5316) and the Annexin V-FITC apoptosis detection kit were obtained from MilliporeSigma. The antibody against survivin (2808) and the Metafectene Pro transfection reagent were purchased from Cell Signaling Technology and Bion-tex, respectively. The enhanced chemiluminescence reagent was from GE Healthcare. The matchmaker mammalian two hybrid assay kit and the Great Escape SEAP Chemiluminescence assay kit were purchased from Clontech. Cell culture media and fetal bovine serum were from Corning and Applied Biosystems-Life Technologies, respectively. All other chemicals were purchased from Sigma or Fisher Scientific.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cell Lines</h3><div class="NLM_p">The human prostate cancer cell lines C4-2, PC-3, Du145, LNCAP, and 22Rv1 were purchased from and authenticated by ATCC. All cell lines were maintained at 37 °C in 5% CO<sub>2</sub> and grown in RPMI with 10% fetal bovine serum.</div><div class="NLM_p last">To generate C4-2 cells with stable expression of HA-tagged survivin, 2 × 10<sup>6</sup> cells were plated in a 10 cm dish and transfected with 10 μg of pcDNA3.1 vector control or HA-survivin cDNA cloned in pcDNA3.1 vector using Metafectene pro as we previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> At 48 h after transfection, cells were harvested and replated in a fresh 10 cm dish at 2 × 10<sup>5</sup> cells/dish followed by selection using 0.8 mg/mL G418 with media and G418 changed every 72 h until colonies were visible for cloning. The stable clones were maintained with 0.2 mg/mL G418.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Construct Engineering</h3><div class="NLM_p last">For the mammalian two hybrid assay, we engineered two constructs encoding GAL4–survivin and VP16–survivin fusion proteins using pBIND and pACT vectors, respectively, in the ClonTech Matchmaker Mammalian Two Hybrid Assay kit<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as instructed by the manufacturer. Briefly, the cDNA encoding the open reading frame of survivin was amplified by PCR using primers 5′-AAGAATTCGGCGGCGGCGGCGGCGATGGGTGCCCCGACGTTGCCC-3′ (forward) and 5′-AACTCGAGTCAATCCATGGCAGCCAGCTGCTC-3′ (reverse) and cloned into pGEM-T easy vector (Promega). The resulting plasmid was then digested with <i>Eco</i>RI, blunt ended, and digested again using <i>Xho</i>I to release the PCR insert, which was then cloned into pBIND and pACT digested with <i>Bam</i>H1, blunt-ended, and then digested with <i>Sal</i>1. The resulting plasmids, pBIND-survivin and pACT-survivin, were validated by sequencing.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Survivin Mammalian Two Hybrid Assay</h3><div class="NLM_p last">The mammalian two hybrid assay was performed using the ClonTech Matchmaker Mammalian Two Hybrid Assay kit with the two newly engineered fusion plasmids as described above. Briefly, DU145 cells were seeded in 12-well plates at 1 × 10<sup>5</sup> cells/well and cultured for 24 h followed by transfection using pBIND-survivin and pACT-survivin (0.45 μg/well) along with the pGSEAP reporter plasmid (0.09 μg/well) and firefly luciferase reporter plasmid (30 ng/well). Two days after transfection, media was changed and cells were treated with DMSO, LQZ-7, or LQZ-7 analogues for 24 h followed by determination of SEAP activity using the Takara ClonTech SEAP Great Escape chemiluminescence assay kit 2.0. Luciferase activity was also measured as a control for transfection efficiency.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methylene Blue Survival Assay</h3><div class="NLM_p last">The methylene blue survival assay was performed as previously described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Briefly, prostate cancer cells were seeded at 2000–3500 cells per well and treated with various concentrations of LQZ-7 or its analogues for 72 h. Media Technology and Biontex, respectively. The enhancedwas then removed, and cells were fixed with methanol for 30 min and subsequently stained with 100 μL of 1% methylene blue (diluted in 10 mM borate buffer) for 1 h. The cells were then washed 3 times with 10 mM borate buffer and then allowed to air-dry for 30 min. One hundred microliters of 100% ethanol/0.1 M HCl (1:1) was added to each well to dissolve the methylene blue stain, and OD<sub>650nm</sub> was measured. The data were analyzed using GraphPad Prism software to generate fitted curves and IC<sub>50</sub>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Survivin Half-Life Determination</h3><div class="NLM_p last">The effect of <b>7I</b> on survivin half-life was performed as previously described.<a onclick="showRef(event, 'ref19 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref23">(19,23)</a> Briefly, PC-3 or C4-2 cells were pretreated with 10 μM cycloheximide for 1 h followed by incubation with or without 10 μM <b>7I</b> for different times (0–6 h). The cells were then harvested for Western Blot analysis of survivin.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Annexin V Apoptosis Assay</h3><div class="NLM_p last">The apoptosis assay was performed as detailed in the Annexin V-FITC kit from BioVision. Briefly, cells were treated with 3 μM <b>7I</b> or DMSO control for 48 h followed by harvest, washing, and staining with annexin V-FITC antibody and propidium iodide. The stained cells were then analyzed using flow cytometry with excitation at 488 and 530 nm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>In Vivo</i> Efficacy</h3><div class="NLM_p last"><i>In vivo</i> studies using animals were approved by IACUC at Indiana University School of Medicine. For the <i>in vivo</i> efficacy study, 3 × 10<sup>6</sup> PC-3 cells in media were implanted in the hind flanks of 6-week old NSG male mice. After the tumor volume reached approximately 100 mm<sup>3</sup> in volume, the mice were randomized into two groups (5 mice/group). The mice were given 200 μL of either vehicle (90% corn oil/10% DMSO) or <b>7I</b> (100 mg/kg) via oral gavage every other day for a total of ten treatments. The body weight and tumor size were measured every 2 days. At the end of the study mice were sacrificed, and tumors were excised for Western blot and IHC analysis of survivin expression.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Statistical Analysis</h3><div class="NLM_p last">All statistical analysis was performed using the program GraphPad Prism. Three independent experiments were performed for each study. Data presented is the mean ± standard deviation unless otherwise noted. All <i>p</i>-values were calculated using the Prism program via Student <i>t</i> tests or one-way ANOVA followed by post hoc test depending on the number of groups being compared.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemical Synthesis and Methods</h3><div class="NLM_p">To access the quinoxaline diamine derivatives (<b>7I</b>, <b>7J</b>, and <b>7K</b>), commercially available 1,4-dihydro-2,3-quinoxalinedione (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) was used as the starting point. Treating 1,4-dihydro-2,3-quinoxalinedione (<b>1</b>) with 4-fluoroaniline (<b>2</b>) or 2,3-dimethyl aniline (<b>3</b>) in refluxing ethanol afforded <b>7I</b> and <b>7J</b>, respectively. When 4-<i>tert</i>-butyl aniline (<b>4</b>) was used, the reaction needed to be heated in DMSO to give the desired product <b>7K</b>. When a 1:1 mixture of 2,3-quinoxalinedione (<b>1</b>) and 4-fluoroaniline (<b>2</b>) was treated with AlCl<sub>3</sub> in DCE at an elevated temperature, monosubstituted product <b>5</b> was obtained, which further underwent another nucleophilic substitution with either <b>6a</b> or <b>6b</b> to afford <b>7G</b> and <b>7H</b>, respectively.</div><div class="NLM_p">All chemical reactions were performed using standard syringe techniques under argon. Starting materials and reagents were used as received from commercial suppliers. Acetonitrile (CH<sub>3</sub>CN), methanol (MeOH), and toluene were purified by passing the previously degassed solvents through activated alumina columns. Dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) and tetrahydrofuran (THF) were distilled prior to use.</div><div class="NLM_p">All compounds were purified using flash chromatography with silica gel (230–400 mesh). Thin layer chromatography (TLC) was performed using glass-backed silica plates (Silicycle). NMR spectra were recorded on a Bruker ARX-400 spectrometer or AV-500 spectrometer at room temperature. Chemical shifts δ (in ppm) are given in reference to the solvent signal. <sup>1</sup>H NMR data are reported as follows: chemical shifts (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quin = quintuplet, m = multiplet, br = broad), coupling constant (Hz), and integration. <sup>13</sup>C NMR data are reported in terms of chemical shift and multiplicity. IR data were recorded on a Thermo Nicolet Nexus 470 FTIR. Electronspray ionization mass spectrometry data for compound characterization were determined using an Advion Expression CMS instrument. The purity was confirmed to be >95% using Waters ACQUITY UPC2 system.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for the Synthesis of Quinoxaline Amine (<b>5</b>)</h4><div class="NLM_p last">To a flame-dried round-bottom flask charged with a stir bar, commercially available 2,3-dichloroquinoxaline (<b>1</b>) (170 mg, 0.85 mmol, 1.0 equiv), 4-fluoroaniline (<b>2</b>) (0.081 mL, 0.85 mmol, 1.0 equiv), AlCl<sub>3</sub> (125.3 mg, 0.94 mmol, 1.1 equiv), and DCE (4.25 mL, 0.2M) were added sequentially. The reaction mixture was then stirred at 80 °C for 16 h. After this period, the reaction was cooled to room temperature and quenched with ice-cold water (10 mL) while stirring. Stirring was continued for an additional 10 min. The reaction was then extracted with EtOAc (three times), and the combined organic layers were washed with ice-cold water two times. The organics were then dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography using hexanes–EtOAc (49:1 to 20:1) to give the pure product as a yellow solid. Yield: 92.2 mg, 40%. All spectroscopic data matched that previously reported in the literature.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure for the Synthesis of Quinoxaline Amine Carboxamides <b>7G</b> and <b>7H</b> from Intermediate (<b>5)</b></h4><div class="NLM_p">To a suspension of NaH (60% in mineral oil, 14.4 mg, 0.36 mmol, 2.0 equiv) in 0.8 mL of DMF was added the desired benzamide (0.36 mmol, 2.0 equiv) The reaction mixture was stirred at room temperature for 1 h. After the suspension turned light yellow, 3-chloro-<i>N</i>-(4-fluorophenyl)quinoxalin-2-amine (<b>5</b>, 50 mg, 0.18 mmol, 1.0 equiv) in DMF (0.2 mL) was added slowly, and the solution turned dark red instantly. The reaction mixture was then stirred at 150 °C for 4 h and then cooled to room temperature before it was quenched with ice-cold water (3 mL). The reaction mixture was then extracted with EtOAc (three times), and the combined organic layers were dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The crude product was then purified by column chromatography to give a bright yellow solid.</div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>N</i>-(3-((4-Fluorophenyl)amino)quinoxalin-2-yl)benzo[<i>d</i>][1,3]dioxole-5-carboxamide (<b>7G</b>)</h5><div class="NLM_p last">Analog <b>7G</b> was synthesized from corresponding intermediate <b>5</b> and <b>6a</b>. Column chromatography was performed using a DCM/hexanes (3:1) mixture to give the pure product (yellow solid, 5% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 9.04 (s, 1H), 8.01–7.94 (m, 3H), 7.77 (d, <i>J</i> = 1.6 Hz, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (ddd, <i>J</i> = 8.3, 6.6, 2.1 Hz, 1H), 7.38–7.31 (m, 2H), 7.14 (t, <i>J</i> = 8.7 Hz, 2H), 6.93 (d, <i>J</i> = 8.2 Hz, 1H), 6.09 (s, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 179.12, 159.85, 157.92, 151.43, 147.84, 145.96, 145.19, 135.15, 134.81, 131.33, 126.66, 126.59, 125.90, 125.22, 124.75, 121.23, 116.84, 115.81, 115.63, 109.30, 107.95, 101.78. IR (neat, cm<sup>–1</sup>): ν = 3319, 2921, 1593, 1546, 1506, 1483, 1437, 1382, 1356, 1292, 1255, 1209, 1192, 1156, 1104, 1038, 926, 832, 808. MS (ESI): <i>m</i>/<i>z</i> 403.1 found for C<sub>22</sub>H<sub>16</sub>FN<sub>4</sub>O<sub>3</sub>[M + H]<sup>+</sup>.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>N</i>-(3-((4-Fluorophenyl)amino)quinoxalin-2-yl)benzamide (<b>7H</b>)</h5><div class="NLM_p last">Analog <b>7H</b> was synthesized from corresponding intermediate <b>5</b> and <b>6b</b>. Column chromatography was performed using a hexanes/EtOAc (5.6:1) mixture to give the pure product (yellow solid, 58% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 9.06 (s, 1H), 8.30 (d, <i>J</i> = 7.5 Hz, 2H), 7.98–7.89 (m, 2H), 7.98–7.89 (m, 1H), 7.61–7.55 (m, 1H), 7.51 (t, <i>J</i> = 7.5 Hz, 2H), 7.43–7.37 (m, 1H), 7.35–7.27 (m, 1H), 7.11 (t, <i>J</i> = 8.5 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 180.15, 159.91, 157.98, 146.00, 145.41, 136.90, 135.37, 134.95, 132.64, 129.44, 128.48 (2C), 126.80, 126.76, 126.00, 124.72, 121.20, 121.14, 117.01, 115.89, 115.71. IR (neat, cm<sup>–1</sup>): ν = 3316, 3066, 1592, 1551, 1506, 1483, 1448, 1413, 1385, 1356, 1314, 1291, 1210, 1156, 1124, 1100, 1068, 1024, 921, 864, 831. MS (ESI): <i>m</i>/<i>z</i> 359.2 found for C<sub>21</sub>H<sub>16</sub>FN<sub>4</sub>O[M + H]<sup>+</sup>.</div></div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Quinoxaline-2,3-Diamines (<b>7I</b> and <b>7J</b>)</h4><div class="NLM_p">To a flame-dried round bottomed flask, commercially available 2,3-dichloroquinoxaline (<b>1</b>, 200 mg, 1.0 mmol, 1.0 equiv), substituted anilines (<b>2</b> or <b>3</b>, 2.2 mmol, 2.2 equiv), and ethanol (5.0 mL, 0.2 M) were added sequentially. The reaction mixture was then refluxed for 16 h. After reaching room temperature, the solvent was slowly removed under reduced pressure. The resulting solid was dissolved in EtOAc (10 mL), washed with water and brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to give the crude product. The crude product was then purified by column chromatography.</div><div id="sec4_10_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i><sup>2</sup>,<i>N</i><sup>3</sup>-Bis(4-fluorophenyl)quinoxaline-2,3-diamine (<b>7I</b>)</h5><div class="NLM_p last">Analog <b>7I</b> was synthesized from commercially available <b>1</b> and 4-fluoroaniline (<b>2</b>). Column chromatography was performed using a hexanes/EtOAc (20:1 to 3:1) mixture to give the pure product (yellow solid, 52% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.06 (s, 2H), 7.95–7.75 (m, 4H), 7.53 (dd, <i>J</i> = 6.1, 3.5 Hz, 2H), 7.33 (dd, <i>J</i> = 6.1, 3.4 Hz, 2H), 7.24 (t, <i>J</i> = 8.9 Hz, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 158.74 (2C), 156.84 (2C), 141.19, 141.16, 136.49, 136.13, 125.34, 125.15, 125.11, 122.37, 122.31, 115.29 (2C), 115.26 (2C), 115.11, 115.09 (2C). IR (neat, cm<sup>–1</sup>): ν = 3386, 2925, 1644, 1616, 1574, 1537, 1501, 1449, 1410, 1328, 1301, 1212, 1155, 1118, 1098, 1012, 923, 830. MS (ESI): <i>m</i>/<i>z</i> 349.2 found for C<sub>20</sub>H<sub>15</sub>F<sub>2</sub>N<sub>4</sub>[M + H]<sup>+</sup>.</div></div><div id="sec4_10_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i><sup>2</sup>,<i>N</i><sup>3</sup>-Bis(2,3-dimethylphenyl)quinoxaline-2,3-diamine (<b>7J</b>)</h5><div class="NLM_p last">Analog <b>7J</b> was synthesized from commercially available <b>1</b> and 2,3-dimethylaniline (<b>3</b>). Column chromatography was performed using a hexanes/EtOAc (49:1 to 20:1) mixture to give the pure product (light brown solid, 16% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.52 (s, 2H), 7.38–7.23 (m, 4H), 7.22–7.12 (m, 4H), 7.09 (d, <i>J</i> = 7.6 Hz, 2H), 2.32 (s, 6H), 2.11 (s, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 142.59 (2C), 137.72 (2C), 137.15 (2C), 136.62 (2C), 132.27 (2C), 126.88 (2C), 125.47 (2C), 125.05 (2C), 124.30 (2C), 124.16 (2C), 20.29 (2C), 14.56 (2C). IR (neat, cm<sup>–1</sup>): ν = 3312, 2916, 1640, 1614, 1567, 1541, 1463, 1381, 1351, 1324, 1258, 1215, 1181, 1119, 1089, 1060, 990, 927, 896, 779. MS (ESI): <i>m</i>/<i>z</i> 369.2 found for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>[M + H]<sup>+</sup>.</div></div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedure for the Synthesis of Quinoxaline-2,3-diamine (<b>7K</b>)</h4><div class="NLM_p">A mixture of 2,3-dichloroquinoxaline (<b>1</b>, 50 mg, 0.25 mmol, 1.0 equiv), 4-<i>tert</i>-butylaniline (<b>4</b>, 1.25 mmol, 5.0 equiv) and DMSO (2.5 mL, 0.1 M) in a flame-dried round-bottomed flask was heated at 130 °C for 2.5 h. After this period, the reaction mixture was cooled to room temperature, diluted with EtOAc (2.5 mL), and poured into ice–water (10 mL). The organic phase was then washed with ice-cold water two times, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude product was then purified by column chromatography using hexanes/EtOAc (20:1) to give the pure product.</div><div id="sec4_10_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i><sup>2</sup>,<i>N</i><sup>3</sup>-Bis(4-(<i>tert</i>-butyl)phenyl)quinoxaline-2,3-diamine (<b>7K</b>)</h5><div class="NLM_p last">Light brown oil, 23% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.97 (s, 2H), 7.82 (d, <i>J</i> = 8.7 Hz, 4H), 7.52 (dd, <i>J</i> = 6.1, 3.4 Hz, 2H), 7.42 (d, <i>J</i> = 8.7 Hz, 4H), 7.32 (dd, <i>J</i> = 6.1, 3.4 Hz, 2H), 1.32 (s, 18H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 144.96 (2C), 141.12 (2), 137.55 (2C), 136.19 (2C), 125.24 (4C), 124.93 (4C), 120.35 (4C), 34.06 (2C), 31.31 (6C). IR (neat, cm<sup>–1</sup>): ν = 3385, 2958, 2902, 2865, 1640, 1613, 1586, 1570, 1513, 1450, 1408, 1361, 1330, 1315, 1294, 1266, 1245, 1191, 1144, 1111, 1016, 940, 858, 831. MS (ESI): <i>m</i>/<i>z</i> 425.3 found for C<sub>28</sub>H<sub>33</sub>N<sub>4</sub>[M + H]<sup>+</sup>.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00475" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00475?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00475</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Dose–response curves for all compounds for survival of human prostate cancer cell lines C4-2 and PC-3 and for <b>7I</b> for cell lines DU145, PC-3, C4-2, 22RV-1, and LNCaP and C4-2 stably overexpressing survivin, mean wet weight of major organs in <b>7I</b> treated mice, and purity analysis of <b>7I</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf">jm0c00475_si_001.pdf (267.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_002.csv">jm0c00475_si_002.csv (0.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00475" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingji Dai</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7956-6426" title="Orcid link">http://orcid.org/0000-0001-7956-6426</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b5d8dfd1d4dcf5c5c0c7d1c0d09bd0d1c0"><span class="__cf_email__" data-cfemail="fe93949a9f97be8e8b8c9a8b9bd09b9a8b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing-Yuan Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Indiana
University School of Medicine, Indianapolis, Indiana 46202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of Toledo College
of Medicine and Life Sciences, Toledo, Ohio 43614, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a5cfcccbc2dcd0c4cb8bc9ccd0e5d0d1cac9c0c1ca8bc0c1d0"><span class="__cf_email__" data-cfemail="95fffcfbf2ece0f4fbbbf9fce0d5e0e1faf9f0f1fabbf0f1e0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian-Ting Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Indiana
University School of Medicine, Indianapolis, Indiana 46202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cancer Biology, University of Toledo
College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2803-9914" title="Orcid link">http://orcid.org/0000-0002-2803-9914</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b71727a756f72757c3561737a757c5b6e6f74777e7f74357e7f6e"><span class="__cf_email__" data-cfemail="b6dcdfd7d8c2dfd8d198ccded7d8d1f6c3c2d9dad3d2d998d3d2c3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Peery</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Indiana
University School of Medicine, Indianapolis, Indiana 46202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwaku Kyei-Baffour</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zizheng Dong</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Indiana
University School of Medicine, Indianapolis, Indiana 46202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cancer Biology, University of Toledo
College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianguo Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Cancer Biology, University of Toledo
College of Medicine and Life Sciences, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pedro de Andrade
Horn</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported in part by the DOD-CDMRP Grant PC131242 (J.T.Z.) and NIH Grants R01 GM127656 (J.Y.L.) and R35 GM128570 (M.D.). M.D. thanks the NIH, Grant P30 CA023168, for supporting shared NMR resources to Purdue Center for Cancer Research.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors wish to thank the University of Toledo Integrated Core Facilities for histology analysis of xenograft tumors.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">X-linked IAP</p></td></tr><tr><td class="NLM_term">CIAP</td><td class="NLM_def"><p class="first last">cellular IAP</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor kappa-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">BIRC5</td><td class="NLM_def"><p class="first last">baculoviral IAP repeat containing 5</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">hemagglutinin</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted alkaline phosphatase.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdecia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1038/76838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2F77929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10876248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslKnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=602-608&author=M.+A.+Verdeciaauthor=H.+Huangauthor=E.+Dutilauthor=D.+A.+Kaiserauthor=T.+Hunterauthor=J.+P.+Noel&title=Structure+of+the+human+anti-apoptotic+protein+survivin+reveals+a+dimeric+arrangement&doi=10.1038%2F76838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement</span></div><div class="casAuthors">Verdecia, Mark A.; Huang, Han-Kuei; Dutil, Erica; Kaiser, Donald A.; Hunter, Tony; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Survivin is a 16.5 kDa protein that is expressed during the G2/M phase of the cell cycle and is hypothesized to inhibit a default apoptotic cascade initiated in mitosis.  This inhibitory function is coupled to survivin's localization to the mitotic spindle.  To begin to address the structural basis of survivin's function, we report the x-ray crystal structure of a recombinant form of full length survivin to 2.58 Å resoln.  Survivin consists of two defined domains including an N-terminal Zn2+-binding BIR domain linked to a 65 Å amphipathic C-terminal α-helix.  The crystal structure reveals an extensive dimerization interface along a hydrophobic surface on the BIR domain of each survivin monomer.  A basic patch acting as a sulfate/phosphate-binding module, an acidic cluster projecting off the BIR domain, and a solvent-accessible hydrophobic surface residing on the C-terminal amphipathic helix, are suggestive of functional protein-protein interaction surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_Qka4OvVTrVg90H21EOLACvtfcHk0lii77jO2TKTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslKnurs%253D&md5=3af2584ef6f47edbd96d875b9789e878</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F77929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F77929%26sid%3Dliteratum%253Aachs%26aulast%3DVerdecia%26aufirst%3DM.%2BA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DDutil%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DD.%2BA.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructure%2520of%2520the%2520human%2520anti-apoptotic%2520protein%2520survivin%2520reveals%2520a%2520dimeric%2520arrangement%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D602%26epage%3D608%26doi%3D10.1038%2F76838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc-Brude, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brash, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchisio, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span> <span> </span><span class="NLM_article-title">Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1172/JCI13345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1172%2FJCI13345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11581300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Crsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=991-999&author=D.+Grossmanauthor=P.+J.+Kimauthor=O.+P.+Blanc-Brudeauthor=D.+E.+Brashauthor=S.+Togninauthor=P.+C.+Marchisioauthor=D.+C.+Altieri&title=Transgenic+expression+of+survivin+in+keratinocytes+counteracts+UVB-induced+apoptosis+and+cooperates+with+loss+of+p53&doi=10.1172%2FJCI13345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53</span></div><div class="casAuthors">Grossman, Douglas; Kim, Paul J.; Blanc-Brude, Olivier P.; Brash, Douglas E.; Tognin, Simona; Marchisio, Pier Carlo; Altieri, Dario C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">991-999</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis protein survivin has been implicated in both cell cycle control and apoptosis resistance.  To discriminate between these different roles, we used transgenic expression of survivin in the skin as a model for cell proliferation, differentiation, and apoptosis.  Transgenic mice expressing survivin under the control of a keratin-14 promoter developed normally, without histol. abnormalities of the skin or hair, epidermal hyperplasia, or developmental abnormalities of basal or suprabasal epidermis.  Keratinocyte proliferation assessed under basal conditions, or after UV-B (UVB) irradn., or phorbol ester stimulation was unchanged in survivin transgenic mice.  In contrast, survivin expression inhibited UVB-induced apoptosis in vitro and in vivo (i.e., sunburn cell formation), whereas it did not affect Fas-induced cell death.  When crossed with p53 knockout mice, transgenic expression of survivin in a p53+/- background substituted for the loss of a second p53 allele and further inhibited UVB-induced apoptosis.  These data provide the first in vivo evidence that survivin inhibits apoptosis and suggest that this pathway may oppose the elimination of cancerous cells by p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_r7Bt8tjTbLVg90H21EOLACvtfcHk0lgheu7xjuXnpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Crsrw%253D&md5=1947263b287c0ba7231b42741d41a3c6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1172%2FJCI13345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13345%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DP.%2BJ.%26aulast%3DBlanc-Brude%26aufirst%3DO.%2BP.%26aulast%3DBrash%26aufirst%3DD.%2BE.%26aulast%3DTognin%26aufirst%3DS.%26aulast%3DMarchisio%26aufirst%3DP.%2BC.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DTransgenic%2520expression%2520of%2520survivin%2520in%2520keratinocytes%2520counteracts%2520UVB-induced%2520apoptosis%2520and%2520cooperates%2520with%2520loss%2520of%2520p53%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D991%26epage%3D999%26doi%3D10.1172%2FJCI13345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: blocking the road to death’s door</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+blocking+the+road+to+death%E2%80%99s+door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0lgheu7xjuXnpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoufias, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, R. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(05)00020-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2FS1097-2765%2805%2900020-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10949039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls1KlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=183-189&author=L.+Chantalatauthor=D.+A.+Skoufiasauthor=J.+P.+Klemanauthor=B.+Jungauthor=O.+Didebergauthor=R.+L.+Margolis&title=Crystal+structure+of+human+survivin+reveals+a+bow+tie-shaped+dimer+with+two+unusual+alpha-helical+extensions&doi=10.1016%2FS1097-2765%2805%2900020-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual α-helical extensions</span></div><div class="casAuthors">Chantalat, Laurent; Skoufias, Dimitrios A.; Kleman, Jean-Philippe; Jung, Barbara; Dideberg, Otto; Margolis, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">183-189</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Survivin is a mitotic spindle-assocd. protein involved in linking mitotic spindle function to activation of apoptosis in mammalian cells.  The structure of the full-length human survivin has been detd. by x-ray crystallog. to 2.7 Å.  Strikingly, the structure forms a very unusual bow tie-shaped dimer.  It does not dimerize through a C-terminal coiled-coil, contrary to sequence anal. prediction.  The C-terminal helixes contain hydrophobic clusters with the potential for protein-protein interactions.  The unusual shape and dimensions of survivin suggest it serves an adaptor function through its α-helical extensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYbdoHgym3LVg90H21EOLACvtfcHk0lgheu7xjuXnpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls1KlsLs%253D&md5=6eeced36c940cb2a88acd83d7d86bf11</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900020-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900020-1%26sid%3Dliteratum%253Aachs%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DSkoufias%26aufirst%3DD.%2BA.%26aulast%3DKleman%26aufirst%3DJ.%2BP.%26aulast%3DJung%26aufirst%3DB.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DMargolis%26aufirst%3DR.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520human%2520survivin%2520reveals%2520a%2520bow%2520tie-shaped%2520dimer%2520with%2520two%2520unusual%2520alpha-helical%2520extensions%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D183%26epage%3D189%26doi%3D10.1016%2FS1097-2765%2805%2900020-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5315</span>– <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=9850056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5315-520&author=I.+Tammauthor=Y.+Wangauthor=E.+Sausvilleauthor=D.+A.+Scudieroauthor=N.+Vignaauthor=T.+Oltersdorfauthor=J.+C.+Reed&title=IAP-family+protein+survivin+inhibits+caspase+activity+and+apoptosis+induced+by+Fas+%28CD95%29%2C+Bax%2C+caspases%2C+and+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs</span></div><div class="casAuthors">Tamm, Ingo; Wang, Yan; Sausville, Ed; Scudiero, Dominic A.; Vigna, Nicole; Oltersdorf, Tilman; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5315-5320</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Survivin is a member of the inhibitor of apoptosis protein (IAP) family.  We investigated the antiapoptotic mechanism of Survivin, as well as its expression in 60 human tumor cell lines used for the National Cancer Institute's anti-cancer drug screening program.  In cotransfection expts., cell death induced by Bax or Fas (CD 95) was partially inhibited (mean ± SD, 65% ± 8%) by Survivin, whereas XIAP, another IAP family member, almost completely blocked cell death (93% ± 4%) under the same conditions.  Survivin and XIAP also protected 293 cells from apoptosis induced by overexpression of procaspase-3 and -7 and inhibited the processing of these zymogens into active caspases.  In vitro binding expts. indicated that, like other IAP-family proteins, Survivin binds specifically to the terminal effector cell death proteases, caspase-3 and -7, but not to the proximal initiator protease caspase-8.  Using a cell-free system in which cytosolic exts. were derived from control- or Survivin-transfected cells and where caspases were activated either by addn. of cytochrome c and dATP or by adding recombinant active caspase-8, Survivin was able to substantially reduce caspase activity, as measured by cleavage of a tetrapeptide substrate, AspGluValAsp-aminofluorocoumarin.  Similar results were obtained in intact cells when Survivin was overexpressed by gene transfection and caspase activation was induced by the anticancer drug etoposide.  Survivin was expressed in all 60 cancer cell lines analyzed, with highest levels in breast and lung cancers and lowest levels in renal cancers.  These findings indicate that Survivin, which is commonly expressed in human tumor cell lines, can bind the effector cell death proteases caspase-3 and -7 in vitro and inhibits caspase activity and cell death in cells exposed to diverse apoptotic stimuli.  Although quant. differences may exist, these observations suggest commonality in the mechanisms used by IAP-family proteins to suppress apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtAMNXwxGQWbVg90H21EOLACvtfcHk0lh4NnKE9MWGRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSkt7w%253D&md5=32dd3234c150de44dce8ce501c6b0b65</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DVigna%26aufirst%3DN.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DIAP-family%2520protein%2520survivin%2520inhibits%2520caspase%2520activity%2520and%2520apoptosis%2520induced%2520by%2520Fas%2520%2528CD95%2529%252C%2520Bax%252C%2520caspases%252C%2520and%2520anticancer%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5315%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peereboom, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desideri, S.</span></span>; <span class="NLM_contrib-group">Adult Brain Tumor Consortium</span> <span> </span><span class="NLM_article-title">Phase I study of terameprocol in patients with recurrent high-grade glioma</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nor230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1093%2Fneuonc%2Fnor230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=22323663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=511-517&author=S.+A.+Grossmanauthor=X.+Yeauthor=D.+Peereboomauthor=M.+R.+Rosenfeldauthor=T.+Mikkelsenauthor=J.+G.+Supkoauthor=S.+Desideriauthor=Adult+Brain+Tumor+Consortium&title=Phase+I+study+of+terameprocol+in+patients+with+recurrent+high-grade+glioma&doi=10.1093%2Fneuonc%2Fnor230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of terameprocol in patients with recurrent high-grade glioma</span></div><div class="casAuthors">Grossman, Stuart A.; Ye, Xiaobu; Peereboom, David; Rosenfeld, Myrna R.; Mikkelsen, Tom; Supko, Jeffrey G.; Desideri, Serena</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Terameprocol is a global transcription inhibitor that affects cell division apoptosis, drug resistance, hypoxia responsive genes, and radiation resistance in hypoxia.  A multicenter, dose-escalation study was conducted in heavily pretreated patients with recurrent, measurable, high-grade gliomas.  Terameprocol was administered i.v. for 5 consecutive days each month and discontinued for toxicity or progression.  Patients taking enzyme-inducing antiseizure drugs (EIASDs) were escalated independently.  Thirty-five patients with a median Karnofsky performance status of 80, median age of 46 years, and median of 2 prior treatment regimens were accrued.  Doses of 750, 1100, 1700, and 2200 mg/day were administered.  Terameprocol was reformulated to avoid acidosis related to the excipient and was well tolerated at 1700 mg/day.  Hypoxia and interstitial nephritis were noted at 2200 mg/day.  Concurrent administration of EIASD did not significantly affect the serum pharmacokinetics of the terameprocol.  Although no responses were seen, stable disease was noted in 9 (28%) of 32 evaluable patients, with 5 (13%) continuing treatment for >6 mo (≥6, 8, 10, 10, and ≥21 mo).  The overall median survival was 5.9 mo.  This phase I study defined the toxicity of terameprocol, detd. that EIASDs do not affect its pharmacokinetics, and identified 1700 mg/day as the dose for future studies.  Preclin. and human data suggest that this novel transcription inhibitor is worthy of further study.  The long-term stability noted in some patients and the lack of assocd. myelosuppression suggest that terameprocol could be safely combined with radiation and temozolomide in newly diagnosed high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXUB0EBZG92LVg90H21EOLACvtfcHk0lh4NnKE9MWGRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hsLrF&md5=3c15db4347f37612b0c64749dab6b835</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor230%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DS.%2BA.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DPeereboom%26aufirst%3DD.%26aulast%3DRosenfeld%26aufirst%3DM.%2BR.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DDesideri%26aufirst%3DS.%26aulast%3D%26atitle%3DPhase%2520I%2520study%2520of%2520terameprocol%2520in%2520patients%2520with%2520recurrent%2520high-grade%2520glioma%26jtitle%3DNeuro%2520Oncol%26date%3D2012%26volume%3D14%26spage%3D511%26epage%3D517%26doi%3D10.1093%2Fneuonc%2Fnor230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, K.</span></span> <span> </span><span class="NLM_article-title">Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1353</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.onc.1203429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10713676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Krsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1346-1353&author=A.+Suzukiauthor=T.+Itoauthor=H.+Kawanoauthor=M.+Hayashidaauthor=Y.+Hayasakiauthor=Y.+Tsutomiauthor=K.+Akahaneauthor=T.+Nakanoauthor=M.+Miuraauthor=K.+Shiraki&title=Survivin+initiates+procaspase+3%2Fp21+complex+formation+as+a+result+of+interaction+with+Cdk4+to+resist+Fas-mediated+cell+death&doi=10.1038%2Fsj.onc.1203429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death</span></div><div class="casAuthors">Suzuki, Atsushi; Ito, Takeshi; Kawano, Hirokazu; Hayashida, Midori; Hayasaki, Yayoi; Tsutomi, Yumi; Akahane, Kouichi; Nakano, Takeshi; Miura, Masayuki; Shiraki, Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1346-1353</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase 3 is an essential death factor for the Fas-mediated cell death, and its inactivation in cells is initiated by an interaction with p21 on mitochondria or with IAP family member ILP.  Survivin is also a member of IAP family and is specifically expressed during embryogenesis and in tumor cells and suppresses cell death signaling.  In our current study, we demonstrated that Survivin translocation into the nucleus is dependent on Fas stimulation and cell proliferation.  Survivin also interacts with the cell cycle regulator Cdk4, leading to Cdk2/Cyclin E activation and Rb phosphorylation.  As a result of Survivin/Cdk4 complex formation, p21 is released from its complex with Cdk4 and interacts with mitochondrial procaspase 3 to suppress Fas-mediated cell death.  Here, we propose that Survivin supports procaspase 3/p21 complex formation as a result of interaction with Cdk4 resulting in suppression of cell death signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEBW9g8qAWLVg90H21EOLACvtfcHk0lh4NnKE9MWGRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Krsbc%253D&md5=77cb69bf5810f45ace180d5547e4f744</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203429%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawano%26aufirst%3DH.%26aulast%3DHayashida%26aufirst%3DM.%26aulast%3DHayasaki%26aufirst%3DY.%26aulast%3DTsutomi%26aufirst%3DY.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DShiraki%26aufirst%3DK.%26atitle%3DSurvivin%2520initiates%2520procaspase%25203%252Fp21%2520complex%2520formation%2520as%2520a%2520result%2520of%2520interaction%2520with%2520Cdk4%2520to%2520resist%2520Fas-mediated%2520cell%2520death%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D1346%26epage%3D1353%26doi%3D10.1038%2Fsj.onc.1203429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabenbauer, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, C.</span></span> <span> </span><span class="NLM_article-title">High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection</span>. <i>Strahlenther. Onkol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1007/s00066-002-1003-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1007%2Fs00066-002-1003-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12240548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BD38vnvVeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2002&pages=426-435&author=F.+Rodelauthor=J.+Hoffmannauthor=G.+G.+Grabenbauerauthor=T.+Papadopoulosauthor=C.+Weissauthor=K.+Guntherauthor=C.+Schickauthor=R.+Sauerauthor=C.+Rodel&title=High+survivin+expression+is+associated+with+reduced+apoptosis+in+rectal+cancer+and+may+predict+disease-free+survival+after+preoperative+radiochemotherapy+and+surgical+resection&doi=10.1007%2Fs00066-002-1003-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection</span></div><div class="casAuthors">Rodel Franz; Hoffmann Jorg; Grabenbauer Gerhard G; Papadopoulos Thomas; Weiss Christian; Gunther Klaus; Schick Christoph; Sauer Rolf; Rodel Claus</div><div class="citationInfo"><span class="NLM_cas:title">Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">426-35</span>
        ISSN:<span class="NLM_cas:issn">0179-7158</span>.
    </div><div class="casAbstract">BACKGROUND:  Spontaneous apoptosis has been shown to predict tumor response to preoperative radiochemotherapy in rectal cancer.  It remains to be elucidated, however, which genetic profile determines whether a tumor is more or less prone to apoptosis.  Recently, a novel member of the inhibitor of apoptosis family, designated survivin, was identified.  In the present study, we investigated the impact of survivin on tumor cell apoptosis and the risk to develop distant metastases or local failure after preoperative radiochemotherapy and surgical resection.  PATIENTS AND METHODS:  The expression of survivin, p53, bcl-2 and the apoptotic index was evaluated by immunohistochemistry on pretreatment biopsies of 54 patients with locally advanced adenocarcinoma of the rectum.  Survivin expression was correlated to clinical and histopathological markers, the levels of spontaneous apoptosis, p53 and bcl-2, as well as to disease-free survival, 5-year rates of local failure and distant disease after preoperative radiochemotherapy and surgical resection.  RESULTS:  Survivin expression inversely correlated with the apoptotic index: High survivin expression was found in 56% of rectal carcinoma biopsies with a median apoptotic index of 1.22%.  Conversely, low survivin expression in tumor cells was associated with a high median apoptotic index (2.29%, p = 0.0001).  High survivin expression also segregated with bcl-2 overexpression (65% bcl-2+ in tumors with high survivin expression as compared to 35% bcl-2+ in tumors with low survivin expression), but the difference was not statistically significant (p = 0.1).  Low survivin expression was significantly related to an increased disease-free survival rate (77% vs 18% at 5 years in tumors with high survivin expression, p = 0.02) and to a reduced risk for distant metastases (18% vs 78% at 5 years in tumors with high survivin expression, p = 0.05) and local failure (6% vs 37% at 5 years in tumors with high survivin expression, p = 0.07).  CONCLUSION:  An inverse correlation between survivin expression and the level of spontaneous apoptosis in pretreatment biopsies suggests that survivin strongly inhibits tumor cell apoptosis in rectal cancer.  Survivin expression may provide a novel predictive indicator for disease-free survival after preoperative radiochemotherapy and surgical resection in rectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp6eZYIX2HUXWEEzDrymxmfW6udTcc2eaX8tBda9Y3NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vnvVeltw%253D%253D&md5=369e1bac65190da60abc2c29fe4c407a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00066-002-1003-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00066-002-1003-y%26sid%3Dliteratum%253Aachs%26aulast%3DRodel%26aufirst%3DF.%26aulast%3DHoffmann%26aufirst%3DJ.%26aulast%3DGrabenbauer%26aufirst%3DG.%2BG.%26aulast%3DPapadopoulos%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DC.%26aulast%3DGunther%26aufirst%3DK.%26aulast%3DSchick%26aufirst%3DC.%26aulast%3DSauer%26aufirst%3DR.%26aulast%3DRodel%26aufirst%3DC.%26atitle%3DHigh%2520survivin%2520expression%2520is%2520associated%2520with%2520reduced%2520apoptosis%2520in%2520rectal%2520cancer%2520and%2520may%2520predict%2520disease-free%2520survival%2520after%2520preoperative%2520radiochemotherapy%2520and%2520surgical%2520resection%26jtitle%3DStrahlenther.%2520Onkol.%26date%3D2002%26volume%3D178%26spage%3D426%26epage%3D435%26doi%3D10.1007%2Fs00066-002-1003-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weck, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunebach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossart, P.</span></span> <span> </span><span class="NLM_article-title">Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-08-2554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1182%2Fblood-2002-08-2554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12576330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=571-576&author=S.+M.+Schmidtauthor=K.+Schagauthor=M.+R.+Mullerauthor=M.+M.+Weckauthor=S.+Appelauthor=L.+Kanzauthor=F.+Grunebachauthor=P.+Brossart&title=Survivin+is+a+shared+tumor-associated+antigen+expressed+in+a+broad+variety+of+malignancies+and+recognized+by+specific+cytotoxic+T+cells&doi=10.1182%2Fblood-2002-08-2554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells</span></div><div class="casAuthors">Schmidt, Susanne M.; Schag, Kerstin; Mueller, Martin R.; Weck, Markus M.; Appel, Silke; Kanz, Lothar; Gruenebach, Frank; Brossart, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Survivin, a member of the inhibitor of apoptosis protein family, is expressed in almost all types of malignancies, making this protein a useful tool for the development of broadly applicable vaccination therapies.  The authors used a recently identified HLA-A2 binding peptide and dendritic cells (DCs) from healthy donors to induce survivin-specific cytotoxic T lymphocytes (CTLs) in vitro.  These T cells efficiently lysed target cells pulsed with the cognate peptide.  Furthermore, survivin-specific CTLs recognized HLA-A2-matched tumor cell lines and primary malignant cells from patients with leukemia in an antigen-specific and HLA-restricted manner as demonstrated with the use of cold target inhibition assays and blocking antibodies.  To validate the immunogenicity of survivin the authors performed the expts. in an autologous setting and used monocyte-derived DCs as targets.  Interestingly, the authors found that DCs up-regulate survivin expression on stimulation with tumor necrosis factor α (TNF-α).  However, these mature DCs were not recognized by survivin-specific CTLs, whereas they lysed autologous mature DCs pulsed with the antigenic peptide or transfected with whole tumor RNA purified from a survivin-expressing cell line.  To further analyze the possible use of survivin-specific CTLs in cancer therapies, the authors induced survivin-specific CTLs using peripheral blood mononuclear cells (PBMNCs) and DCs from a patient with chronic lymphocytic leukemia (CLL).  The in vitro-generated T cells efficiently recognized autologous malignant CLL cells, whereas they spared autologous-purified non-malignant B cells or DCs.  The results demonstrate that survivin epitopes are presented on a broad variety of malignancies and can be applied in vaccination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpcS3EEmOWLVg90H21EOLACvtfcHk0lgI31G7UNFXGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGitL4%253D&md5=0387ca794904d4a52453cfd5d2a6e758</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-08-2554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-08-2554%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%2BM.%26aulast%3DSchag%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DM.%2BR.%26aulast%3DWeck%26aufirst%3DM.%2BM.%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DKanz%26aufirst%3DL.%26aulast%3DGrunebach%26aufirst%3DF.%26aulast%3DBrossart%26aufirst%3DP.%26atitle%3DSurvivin%2520is%2520a%2520shared%2520tumor-associated%2520antigen%2520expressed%2520in%2520a%2520broad%2520variety%2520of%2520malignancies%2520and%2520recognized%2520by%2520specific%2520cytotoxic%2520T%2520cells%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D571%26epage%3D576%26doi%3D10.1182%2Fblood-2002-08-2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothermel, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plescia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchisio, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic cell-division defects and apoptosis induced by interference with survivin function</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1038/70242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2F70242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10587640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK1MXotFaltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=461-466&author=F.+Liauthor=E.+J.+Ackermannauthor=C.+F.+Bennettauthor=A.+L.+Rothermelauthor=J.+Plesciaauthor=S.+Togninauthor=A.+Villaauthor=P.+C.+Marchisioauthor=D.+C.+Altieri&title=Pleiotropic+cell-division+defects+and+apoptosis+induced+by+interference+with+survivin+function&doi=10.1038%2F70242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic cell-division defects and apoptosis induced by interference with survivin function</span></div><div class="casAuthors">Li, Fengzhi; Ackermann, Elizabeth J.; Bennett, C. Frank; Rothermel, Annette L.; Plescia, Janet; Tognin, Simona; Villa, Antonello; Marchisio, Pier Carlo; Altieri, Dario C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">461-466</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">Here we investigate the role of the control of apoptosis in normal cell division.  We show that interference with the expression or function of the apoptosis inhibitor survivin causes caspase-dependent cell death in the G2/M phase of the cell cycle, and a cell-division defect characterized by centrosome dysregulation, multipolar mitotic spindles and multinucleated, polyploid cells.  Use of a dominant-neg. survivin mutant or antisense survivin complementary DNA disrupts a supramol. assembly of survivin, caspase-3 and the cyclin-dependent-kinase inhibitor p21Waf1/Clp1 within centrosomes, and results in caspase-dependent cleavage of p21.  Polyploidy induced by survivin antagonists is accentuated in p21-deficient cells, and cor. by exogenous expression of p21.  These findings show that control of apoptosis and preservation of p21 integrity within centrosomes by survivin are required for normal mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLUS45BjrfRLVg90H21EOLACvtfcHk0ljiajYN78E59g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFaltbo%253D&md5=33245c413e04f44f57097965e3e5eb67</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F70242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F70242%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAckermann%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DC.%2BF.%26aulast%3DRothermel%26aufirst%3DA.%2BL.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DTognin%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DMarchisio%26aufirst%3DP.%2BC.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DPleiotropic%2520cell-division%2520defects%2520and%2520apoptosis%2520induced%2520by%2520interference%2520with%2520survivin%2520function%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26spage%3D461%26epage%3D466%26doi%3D10.1038%2F70242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeger, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowsert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1038/sj.neo.7900091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.neo.7900091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10935509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=235-241&author=J.+Chenauthor=W.+Wuauthor=S.+K.+Tahirauthor=P.+E.+Kroegerauthor=S.+H.+Rosenbergauthor=L.+M.+Cowsertauthor=F.+Bennettauthor=S.+Krajewskiauthor=M.+Krajewskaauthor=K.+Welshauthor=J.+C.+Reedauthor=S.+C.+Ng&title=Down-regulation+of+survivin+by+antisense+oligonucleotides+increases+apoptosis%2C+inhibits+cytokinesis+and+anchorage-independent+growth&doi=10.1038%2Fsj.neo.7900091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth</span></div><div class="casAuthors">Chen, Jun; Wu, Wei; Tahir, Stephen K.; Kroeger, Paul E.; Rosenberg, Saul H.; Cowsert, Lex M.; Bennett, Frank; Krajewski, Stanislaw; Krajewska, Maryla; Welsh, Kate; Reed, John C.; Ng, Shi-Chung</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-241</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Survivin, a member of the inhibitor of apoptosis protein (IAP) family, is detected in most common human cancers but not in adjacent normal cells.  Previous studies suggest that survivin assocs. with the mitotic spindle and directly inhibits caspase activity.  To further investigate the function of survivin, we used a survivin antisense (AS) oligonucleotide to down-regulate survivin expression in normal and cancer cells.  We found that inhibition of survivin expression increased apoptosis and polyploidy while decreasing colony formation in soft agar.  Immunohistochem. showed that cells without survivin can initiate the cleavage furrow and contractile ring, but cannot complete cytokinesis, thus resulting in multinucleated cells.  These findings indicate that survivin plays important roles in a late stage of cytokinesis, as well as in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69BGMgkWGlbVg90H21EOLACvtfcHk0ljiajYN78E59g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGhtLs%253D&md5=10260ead64e27ad7c9e8ccfd9aafd13b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.neo.7900091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.neo.7900091%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DKroeger%26aufirst%3DP.%2BE.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DCowsert%26aufirst%3DL.%2BM.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DKrajewska%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DS.%2BC.%26atitle%3DDown-regulation%2520of%2520survivin%2520by%2520antisense%2520oligonucleotides%2520increases%2520apoptosis%252C%2520inhibits%2520cytokinesis%2520and%2520anchorage-independent%2520growth%26jtitle%3DNeoplasia%26date%3D2000%26volume%3D2%26spage%3D235%26epage%3D241%26doi%3D10.1038%2Fsj.neo.7900091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasof, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B. C.</span></span> <span> </span><span class="NLM_article-title">Livin, a novel inhibitor of apoptosis protein family member</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">3238</span>– <span class="NLM_lpage">3246</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003670200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1074%2Fjbc.M003670200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11024045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3238-3246&author=G.+M.+Kasofauthor=B.+C.+Gomes&title=Livin%2C+a+novel+inhibitor+of+apoptosis+protein+family+member&doi=10.1074%2Fjbc.M003670200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Livin, a novel inhibitor of apoptosis protein family member</span></div><div class="casAuthors">Kasof, Gary M.; Gomes, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3238-3246</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A novel human inhibitor of apoptosis protein (IAP) family member termed Livin was identified, contg. a single baculoviral IAP repeat (BIR) domain and a C-terminal RING finger domain.  The mRNA for livin was not detectable by Northern blot in most normal adult tissues with the exception of the placenta, but was present in developmental tissues and in several cancer cell lines.  Highest levels were obsd. in two melanoma-derived cell lines, G361 and SK-Mel29.  Transfection of livin in HeLa cells resulted in protection from apoptosis induced by expression of FADD, Bax, RIP, RIP3, and DR6.  Similar to other IAP family members, the anti-apoptotic activity of Livin was dependent on the BIR domain.  Livin was also capable of inhibiting DEVD-like caspase activity triggered by tumor necrosis factor-α.  In vitro binding studies demonstrated a direct interaction between Livin and the active form of the downstream caspases, caspase-3 and -7, that was dependent on the BIR domain of Livin.  In addn., the unprocessed and cleaved forms of caspase-9 co-immunopptd. with Livin in vivo, and recombinant Livin could inhibit the activation of caspase-9 induced by Apaf-1, cytochrome c, and dATP.  The subcellular distribution of the transfected Livin was analyzed by immunofluorescence.  Both Livin and Survivin were expressed in the nucleus and in a filamentous pattern throughout the cytoplasm.  In contrast to the apoptotic activity, the C-terminal RING domain mediated its subcellular localization patterning.  Further studies found that transfection of an antisense construct against livin could trigger apoptosis specifically in cell lines expressing livin mRNA.  This was assocd. with an increase in DNA fragmentation and in DEVD-like caspase activity.  Thus, disruption of Livin may provide a strategy to induce apoptosis in certain cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtwzmTk4KEirVg90H21EOLACvtfcHk0ljkrzGJq013gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFWjurg%253D&md5=23e8d7bcdfbc69cb0fa2fad22f6720b0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003670200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003670200%26sid%3Dliteratum%253Aachs%26aulast%3DKasof%26aufirst%3DG.%2BM.%26aulast%3DGomes%26aufirst%3DB.%2BC.%26atitle%3DLivin%252C%2520a%2520novel%2520inhibitor%2520of%2520apoptosis%2520protein%2520family%2520member%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3238%26epage%3D3246%26doi%3D10.1074%2Fjbc.M003670200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olie, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes-Wust, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leech, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangemeister-Wittke, U.</span></span> <span> </span><span class="NLM_article-title">A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10850418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFOlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2805-2809&author=R.+A.+Olieauthor=A.+P.+Simoes-Wustauthor=B.+Baumannauthor=S.+H.+Leechauthor=D.+Fabbroauthor=R.+A.+Stahelauthor=U.+Zangemeister-Wittke&title=A+novel+antisense+oligonucleotide+targeting+survivin+expression+induces+apoptosis+and+sensitizes+lung+cancer+cells+to+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy</span></div><div class="casAuthors">Olie, Robert A.; Simoes-Wust, A. Paula; Baumann, Bettina; Leech, Sian H.; Fabbro, Doriano; Stahel, Rolf A.; Zangemeister-Wittke, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2805-2809</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Survivin, an inhibitor of apoptosis protein, deserves attention as a selective target for cancer therapy because it lacks expression in differentiated adult tissues but is expressed in a variety of human tumors.  The authors designed 20-mer phosphorothioate antisense oligonucleotides targeting different regions of survivin mRNA and investigated their ability to down-regulate survivin mRNA and induce apoptosis in the lung adenocarcinoma cell line A549.  Oligonucleotide 4003, which targets nucleotides 232-251 of survivin mRNA, was identified as the most potent compd.  As measured by real-time PCR, 4003 down-regulated survivin mRNA in a dose-dependent manner with an IC50 of 200 nM.  Its max. effect was achieved at a concn. of 400 nM, at which mRNA was down-regulated by 70%.  As revealed by increased caspase-3-like protease activity, nuclear condensation and fragmentation, and trypan blue uptake, treatment with 4003 induced apoptosis and sensitized tumor cells to the chemotherapeutic agent etoposide.  Oligonucleotide 4003 did not reduce the viability of normal blood leukocytes with marginal levels of survivin mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeR2m75LCs1rVg90H21EOLACvtfcHk0ljkrzGJq013gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFOlsLo%253D&md5=470bc41be64009b9ef134d44d8ad5ab2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlie%26aufirst%3DR.%2BA.%26aulast%3DSimoes-Wust%26aufirst%3DA.%2BP.%26aulast%3DBaumann%26aufirst%3DB.%26aulast%3DLeech%26aufirst%3DS.%2BH.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DStahel%26aufirst%3DR.%2BA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DA%2520novel%2520antisense%2520oligonucleotide%2520targeting%2520survivin%2520expression%2520induces%2520apoptosis%2520and%2520sensitizes%2520lung%2520cancer%2520cells%2520to%2520chemotherapy%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2805%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daidone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span> <span> </span><span class="NLM_article-title">Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1172/JCI0214891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1172%2FJCI0214891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11805141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=285-286&author=M.+Pennatiauthor=G.+Colellaauthor=M.+Foliniauthor=L.+Cittiauthor=M.+G.+Daidoneauthor=N.+Zaffaroni&title=Ribozyme-mediated+attenuation+of+survivin+expression+sensitizes+human+melanoma+cells+to+cisplatin-induced+apoptosis&doi=10.1172%2FJCI0214891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis</span></div><div class="casAuthors">Pennati, Marzia; Colella, Gennaro; Folini, Marco; Citti, Lorenzo; Daidone, Maria Grazia; Zaffaroni, Nadia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-286</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The hammerhead ribozymes targeting the 3' end of the CUA110and the GUC294 (RZ7) triplets in the survivin mRNA were developed as an alternative strategy for survivin inhibition.  To assess the effect of survivin inhibition on the susceptibility of melanoma cells to undergo cisplatin-induced apoptosis, three stably transfected clones, RZ1/C, RZ7/H and mutRZ1/B, were treated with 10 μg/mL of the drug for 1 h.  The presence of apoptotic nuclei in cells stained with propidium iodide under fluorescence microscopy was also detd. at 72 h after treatment.  A considerable increase in the percentage of apoptotic cells was obsd. in RZ1/C and RZ7/H cells, while a very moderate apoptotic response was detected in mutRZ1/B.  The attenuation of survivin expression in the melanoma cell system was insufficient to significantly trigger apoptosis in the absence of other stimuli.  However, the attenuation of survivin expression made the melanoma cells more susceptible to cisplatin-induced apoptosis.  These findings indicated the possible strategy to enhance the chemosensitivity profile of such a drug-refractory human malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwXy-wrux7Vg90H21EOLACvtfcHk0ljkrzGJq013gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVKruw%253D%253D&md5=e5b6eafd6beb5f45cc4881885f647dbc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1172%2FJCI0214891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0214891%26sid%3Dliteratum%253Aachs%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DColella%26aufirst%3DG.%26aulast%3DFolini%26aufirst%3DM.%26aulast%3DCitti%26aufirst%3DL.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DZaffaroni%26aufirst%3DN.%26atitle%3DRibozyme-mediated%2520attenuation%2520of%2520survivin%2520expression%2520sensitizes%2520human%2520melanoma%2520cells%2520to%2520cisplatin-induced%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D285%26epage%3D286%26doi%3D10.1172%2FJCI0214891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaynor, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scoggin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokaslan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becerra, C.</span></span> <span> </span><span class="NLM_article-title">Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12631590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFKiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=931-46&author=N.+S.+Williamsauthor=R.+B.+Gaynorauthor=S.+Scogginauthor=U.+Vermaauthor=T.+Gokaslanauthor=C.+Simmangauthor=J.+Flemingauthor=D.+Tavanaauthor=E.+Frenkelauthor=C.+Becerra&title=Identification+and+validation+of+genes+involved+in+the+pathogenesis+of+colorectal+cancer+using+cDNA+microarrays+and+RNA+interference"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference</span></div><div class="casAuthors">Williams, Noelle Sevilir; Gaynor, Richard B.; Scoggin, Shane; Verma, Udit; Gokaslan, Tunc; Simmang, Clifford; Fleming, Jason; Tavana, Denise; Frenkel, Eugene; Becerra, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">931-946</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to profile gene expression changes in colorectal tumors to identify new targets and strategies for the management of this disease.  cDNA microarray anal. was used to detect differences in gene expression between normal tissue and colon tumors and polyps isolated from 20 patients.  To identify genes that are important in regulating the growth properties of colorectal cancer, RNA interference (RNAi) was used to disrupt expression of several of the overexpressed genes in a colon tumor cell line, HCT116, which showed similar patterns of gene expression as many of the patient tumors.  Expression changes of ≥2-fold in approx. one-third of the patients were consistently obsd. for 2632 of a total of 9592 genes (574 up-regulated genes and 2058 down-regulated genes).  Subsequent anal. of 13 genes by quant. real-time PCR confirmed the reliability of this anal.  RNAi-mediated disruption of the expression of one of these genes, survivin, a potent inhibitor of apoptosis, severely reduced tumor growth both in vitro and in an in vivo xenograft model.  The combined use of microarray anal. and RNAi provides an excellent system to define the role of specific genes that are up-regulated in cancer lead to the increased in vitro and in vivo growth of colon tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMJuqOrM-ibVg90H21EOLACvtfcHk0lh26dQre1T_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFKiurs%253D&md5=71c20301c117690baec91c5c9c00f558</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DGaynor%26aufirst%3DR.%2BB.%26aulast%3DScoggin%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DU.%26aulast%3DGokaslan%26aufirst%3DT.%26aulast%3DSimmang%26aufirst%3DC.%26aulast%3DFleming%26aufirst%3DJ.%26aulast%3DTavana%26aufirst%3DD.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DBecerra%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520validation%2520of%2520genes%2520involved%2520in%2520the%2520pathogenesis%2520of%2520colorectal%2520cancer%2520using%2520cDNA%2520microarrays%2520and%2520RNA%2520interference%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D931%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. H.</span></span> <span> </span><span class="NLM_article-title">Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells</span>. <i>Cancer Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1038/sj.cgt.7700531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.cgt.7700531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12536196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1ymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=87-95&author=K.+S.+Choiauthor=T.+H.+Leeauthor=M.+H.+Jung&title=Ribozyme-mediated+cleavage+of+the+human+survivin+mRNA+and+inhibition+of+antiapoptotic+function+of+survivin+in+MCF-7+cells&doi=10.1038%2Fsj.cgt.7700531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells</span></div><div class="casAuthors">Choi, Kyoung Suk; Lee, Tae Ho; Jung, Myeong Ho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Survivin is a new member of the inhibitor of apoptosis protein (IAP) family that is implicated in the control of cell proliferation and the regulation of cell life span.  This protein is selectively expressed in most human carcinomas but not in normal adult tissues.  To down-regulate a human survivin expression as a strategy for cancer gene therapy, we designed two hammerhead ribozymes (RZ-1, RZ-2) targeting human survivin mRNA.  RZ-1 and RZ-2 efficiently cleaved the human survivin mRNA at nucleotide positions +279 and +289, which was identified by in vitro cleavage assay using in vitro transcribed ribozymes and truncated survivin mRNA substrate.  To investigate the function of the ribozymes in cells, the sequences of the ribozymes were cloned into replication-deficient adenoviral vector and transferred to breast cancer cell, MCF-7.  The infection with adenovirus encoding the ribozymes resulted in a significant redn. of survivin mRNA (74% and 73%, resp.) and protein.  As revealed by nuclear condensation/ fragmentation and flow cytometry anal., inhibition of survivin gene by ribozymes increased apoptosis and sensitivity induced by etoposide or serum starvation.  Our results suggest that the designed hammerhead ribozymes against survivin mRNA are good candidates for feasible gene therapy in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPfmfMBCgloLVg90H21EOLACvtfcHk0lh26dQre1T_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1ymtg%253D%253D&md5=659a930f7e7075a9771868718ceedd6c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700531%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DK.%2BS.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DJung%26aufirst%3DM.%2BH.%26atitle%3DRibozyme-mediated%2520cleavage%2520of%2520the%2520human%2520survivin%2520mRNA%2520and%2520inhibition%2520of%2520antiapoptotic%2520function%2520of%2520survivin%2520in%2520MCF-7%2520cells%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D87%26epage%3D95%26doi%3D10.1038%2Fsj.cgt.7700531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting survivin for therapeutic discovery: past, present, and future promises</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2Fj.drudis.2017.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=28577912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1466-1477&author=R.+C.+Peeryauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Targeting+survivin+for+therapeutic+discovery%3A+past%2C+present%2C+and+future+promises&doi=10.1016%2Fj.drudis.2017.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting survivin for therapeutic discovery: past, present, and future promises</span></div><div class="casAuthors">Peery, Robert C.; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1466-1477</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is overexpressed in cells of almost all cancers but not in most normal tissues in adults.  Survivin expression is required for cancer cell survival and knocking down its expression or inhibiting its function using mol. approaches results in spontaneous apoptosis.  Thus, survivin is an attractive and perhaps ideal target for cancer drug discovery.  However, a US Food and Drug Administration (FDA)-approved drug targeting survivin has yet to emerge.  In this Foundation Review, we examine and evaluate various strategies that have been used to target survivin and the stages of each survivin inhibitor to help understand this lack of success.  We also provide future perspectives moving forward in targeting survivin for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjdIclTWikbVg90H21EOLACvtfcHk0lh26dQre1T_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D&md5=e0c67912f0c8fbd96ba9bd3d454dc879</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520survivin%2520for%2520therapeutic%2520discovery%253A%2520past%252C%2520present%252C%2520and%2520future%2520promises%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26spage%3D1466%26epage%3D1477%26doi%3D10.1016%2Fj.drudis.2017.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aljahdali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">368</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1362-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1186%2Fs13046-019-1362-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=31439015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgsF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=368&author=F.+Liauthor=I.+Aljahdaliauthor=X.+Ling&title=Cancer+therapeutics+using+survivin+BIRC5+as+a+target%3A+what+can+we+do+after+over+two+decades+of+study%3F&doi=10.1186%2Fs13046-019-1362-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?</span></div><div class="casAuthors">Li Fengzhi; Aljahdali Ieman; Ling Xiang; Li Fengzhi; Aljahdali Ieman; Ling Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Survivin (also named BIRC5) is a well-known cancer therapeutic target.  Since its discovery more than two decades ago, the use of survivin as a target for cancer therapeutics has remained a central goal of survivin studies in the cancer field.  Many studies have provided intriguing insight into survivin's functional role in cancers, thus providing promise for survivin as a cancer therapeutic target.  Despite this, moving survivin-targeting agents into and through the clinic remains a challenge.  In order to address this challenge, we may need to rethink current strategies in order to develop a new mindset for targeting survivin.  In this Review, we will first summarize the current survivin mechanistic studies, and then review the status of survivin cancer therapeutics, which is classified into five categories: (i) survivin-partner protein interaction inhibitors, (ii) survivin homodimerization inhibitors, (iii) survivin gene transcription inhibitors, (iv) survivin mRNA inhibitors and (v) survivin immunotherapy.  We will then provide our opinions on cancer therapeutics using survivin as a target, with the goal of stimulating discussion that might facilitate translational research for discovering improved strategies and/or more effective anticancer agents that target survivin for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMtQEKH7hnxdts4TFFB11gfW6udTcc2eaPHMHR7rkWcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgsF2hsA%253D%253D&md5=98ff4475bb1640831f1c42b398b4519c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1362-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1362-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAljahdali%26aufirst%3DI.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DCancer%2520therapeutics%2520using%2520survivin%2520BIRC5%2520as%2520a%2520target%253A%2520what%2520can%2520we%2520do%2520after%2520over%2520two%2520decades%2520of%2520study%253F%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D368%26doi%3D10.1186%2Fs13046-019-1362-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Effective targeting of the survivin dimerization interface with small-molecule inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1158%2F0008-5472.CAN-15-1874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=26744521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1WisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=453-62&author=J.+Qiauthor=Z.+Dongauthor=J.+Liuauthor=R.+C.+Peeryauthor=S.+Zhangauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Effective+targeting+of+the+survivin+dimerization+interface+with+small-molecule+inhibitors&doi=10.1158%2F0008-5472.CAN-15-1874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors</span></div><div class="casAuthors">Qi, Jing; Dong, Zizheng; Liu, Jianguo; Peery, Robert C.; Zhang, Shaobo; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-462</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Many oncoproteins are considered undruggable because they lack enzymic activities.  In this study, we present a small-mol.-based anticancer agent that acts by inhibiting dimerization of the oncoprotein survivin, thereby promoting its degrdn. along with spontaneous apoptosis in cancer cells.  Through a combination of computational anal. of the dimerization interface and in silico screening, we identified one compd. that induced proteasome-dependent survivin degrdn.  Anal. of a set of structural analogs led us to identify a lead compd. (LQZ-7F), which was effective in blocking the survival of multiple cancer cell lines in a low micromolar concn. range.  LQZ-7F induced proteasome-dependent survivin degrdn., mitotic arrest, and apoptosis, and it blocked the growth of human tumors in mouse xenograft assays.  In addn. to providing preclin. proof of concept for a survivin-targeting anticancer agent, our work offers novel in silico screening strategies to therapeutically target homodimeric oncogenic proteins considered undruggable.  Cancer Res; 76(2); 453-62. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFIaf1nDDoJbVg90H21EOLACvtfcHk0ljhUl036352ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1WisA%253D%253D&md5=b8ca613a6f9c029097942e21dc212025</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1874%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DEffective%2520targeting%2520of%2520the%2520survivin%2520dimerization%2520interface%2520with%2520small-molecule%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D453%26epage%3D62%26doi%3D10.1158%2F0008-5472.CAN-15-1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zietman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1002/pros.20263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1002%2Fpros.20263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=15754318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=293-302&author=M.+Zhangauthor=N.+Mukherjeeauthor=R.+S.+Bermudezauthor=D.+E.+Lathamauthor=M.+A.+Delaneyauthor=A.+L.+Zietmanauthor=W.+U.+Shipleyauthor=A.+Chakravarti&title=Adenovirus-mediated+inhibition+of+survivin+expression+sensitizes+human+prostate+cancer+cells+to+paclitaxel+in+vitro+and+in+vivo&doi=10.1002%2Fpros.20263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo</span></div><div class="casAuthors">Zhang, Min; Mukherjee, Neelanjan; Bermudez, R. Scott; Latham, Douglas E.; Delaney, Meaghan A.; Zietman, Anthony L.; Shipley, William U.; Chakravarti, Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Improvements in the response rates to chemotherapy would represent an important advancement in the care of patients with metastatic prostate cancer.  There is accumulating evidence that Survivin, a member of the inhibitor of apoptosis (IAP) family, is assocd. with both cancer progression and drug resistance.  The purpose of this study is to investigate the role of Survivin in paclitaxel-resistance and whether the targeting of Survivin sensitizes prostate cancer cells to paclitaxel.  Human prostate cell lines PC-3, DU-145, and LNCaP were infected with replication-deficient adenoviruses encoding either wild-type Survivin [pAd-S(WT)], to examine Survivin overexpression effects, or a phosphorylation-defective Survivin Thr34→Ala dominant neg. mutant [pAd-S(T34A)], to examine Survivin inactivation effects.  The effects of wild-type or mutant Survivin on spontaneous and paclitaxel-induced apoptosis were investigated both in vitro and in vivo.  Forced overexpression of wild-type Survivin with pAd-S(WT) increased resistance to paclitaxel in all cell lines, both in vitro and in vivo.  Inhibition of Survivin using pAd-S(T34A) resulted in a significant increase in the rate of spontaneous and paclitaxel-induced apoptosis in all cell lines, both in vitro and in vivo.  This effect was abolished by co-treatment with VAD-CHO (Calbiochem, San Diego, CA), a pan-caspase inhibitor, indicating that Survivin normally mediates resistance to paclitaxel through suppression of caspase-mediated apoptosis.  Survivin mediates paclitaxel-resistance in prostate cancer cells.  The inhibition of Survivin sensitizes prostate cancer cells to paclitaxel-induced apoptosis through a caspase-dependant mechanism in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn-rqmz_5WLVg90H21EOLACvtfcHk0ljhUl036352ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFSmtL0%253D&md5=150623b791c6eef14e8093a2d0f31b20</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fpros.20263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.20263%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DN.%26aulast%3DBermudez%26aufirst%3DR.%2BS.%26aulast%3DLatham%26aufirst%3DD.%2BE.%26aulast%3DDelaney%26aufirst%3DM.%2BA.%26aulast%3DZietman%26aufirst%3DA.%2BL.%26aulast%3DShipley%26aufirst%3DW.%2BU.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DAdenovirus-mediated%2520inhibition%2520of%2520survivin%2520expression%2520sensitizes%2520human%2520prostate%2520cancer%2520cells%2520to%2520paclitaxel%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProstate%26date%3D2005%26volume%3D64%26spage%3D293%26epage%3D302%26doi%3D10.1002%2Fpros.20263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(94)90522-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2FS0092-8674%2894%2990522-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=8087847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1994&pages=799-811&author=R.+Faganauthor=K.+J.+Flintauthor=N.+Jones&title=Phosphorylation+of+E2F-1+modulates+its+interaction+with+the+retinoblastoma+gene+product+and+the+adenoviral+E4+19+kDa+protein&doi=10.1016%2FS0092-8674%2894%2990522-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein</span></div><div class="casAuthors">Fagan, Rick; Flint, Kate J.; Jones, Nic</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The transcription factor E2F is regulated through its cyclical interaction with a spectrum of cellular proteins.  One such protein is the product of the retinoblastoma gene (Rb); assocn. of E2F with Rb inhibits its transactivation potential.  However, in adenovirus-infected cells, E2F is complexed to the 19 kDa product of the adenovirus E4 gene.  The authors have studied the interaction of E2F-1 with the Rb and adenovirus E4 proteins and show that phosphorylation of E2F-1 on serine residues 332 and 337 prevented its interaction with Rb but was a prerequisite for interaction with E4.  These residues were phosphorylated in vivo and by p34cdc2 kinase in vitro.  Upon stimulation of serum-starved cells, phosphorylation was induced in the late G1 phase of the cell cycle.  These observations suggest that phosphorylation of E2F-1 is important in the regulation of its activity during the cell cycle and during infection of cells by adenovirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR2N66oy36GrVg90H21EOLACvtfcHk0lgNUn1BW52hzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVaitr8%253D&md5=fe0ad781e738fb267fcc8d5ed2a2c7f9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2894%2990522-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252894%252990522-3%26sid%3Dliteratum%253Aachs%26aulast%3DFagan%26aufirst%3DR.%26aulast%3DFlint%26aufirst%3DK.%2BJ.%26aulast%3DJones%26aufirst%3DN.%26atitle%3DPhosphorylation%2520of%2520E2F-1%2520modulates%2520its%2520interaction%2520with%2520the%2520retinoblastoma%2520gene%2520product%2520and%2520the%2520adenoviral%2520E4%252019%2520kDa%2520protein%26jtitle%3DCell%26date%3D1994%26volume%3D78%26spage%3D799%26epage%3D811%26doi%3D10.1016%2FS0092-8674%2894%2990522-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, C.</span></span> <span> </span><span class="NLM_article-title">Chiasmal and Retrochiasmal Disorders</span>. <i>Int. Ophthalmol. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1097/IIO.0000000000000280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1097%2FIIO.0000000000000280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=31233416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MzgtFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=59-81&author=J.+D.+Beebeauthor=M.+S.+Leeauthor=C.+McClelland&title=Chiasmal+and+Retrochiasmal+Disorders&doi=10.1097%2FIIO.0000000000000280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chiasmal and Retrochiasmal Disorders</span></div><div class="casAuthors">Beebe Johanna D; Lee Michael S; McClelland Collin</div><div class="citationInfo"><span class="NLM_cas:title">International ophthalmology clinics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">59-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYSRsLU9l2_oqdXsLcGTEUfW6udTcc2eZq0Sa1vS5pm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzgtFKitg%253D%253D&md5=b49473461251cc9445f878cfa0c5e879</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1097%2FIIO.0000000000000280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FIIO.0000000000000280%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMcClelland%26aufirst%3DC.%26atitle%3DChiasmal%2520and%2520Retrochiasmal%2520Disorders%26jtitle%3DInt.%2520Ophthalmol.%2520Clin.%26date%3D2019%26volume%3D59%26spage%3D59%26epage%3D81%26doi%3D10.1097%2FIIO.0000000000000280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e5676</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0005676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1371%2Fjournal.pone.0005676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=19479068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BD1MznvVCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=H.+Pengauthor=Z.+Dongauthor=J.+Qiauthor=Y.+Yangauthor=Y.+Liuauthor=Z.+Liauthor=J.+Xuauthor=J.+T.+Zhang&title=A+Novel+Two+Mode-Acting+Inhibitor+of+ABCG2-Mediated+Multidrug+Transport+and+Resistance+in+Cancer+Chemotherapy&doi=10.1371%2Fjournal.pone.0005676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy</span></div><div class="casAuthors">Peng Hui; Dong Zizheng; Qi Jing; Yang Youyun; Liu Yang; Li Zhaomin; Xu Junkang; Zhang Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e5676</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND: Multidrug resistance (MDR) is a major problem in successful treatment of cancers.  Human ABCG2, a member of the ATP-binding cassette transporter superfamily, plays a key role in MDR and an important role in protecting cancer stem cells.  Knockout of ABCG2 had no apparent adverse effect on the mice.  Thus, ABCG2 is an ideal target for development of chemo-sensitizing agents for better treatment of drug resistant cancers and helping eradicate cancer stem cells.  METHODS/PRELIMINARY FINDINGS: Using rational screening of representatives from a chemical compound library, we found a novel inhibitor of ABCG2, PZ-39 (N-(4-chlorophenyl)-2-[(6-{[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-yl)sulfanyl]acetamide), that has two modes of actions by inhibiting ABCG2 activity and by accelerating its lysosome-dependent degradation.  PZ-39 has no effect on ABCB1 and ABCC1-mediated drug efflux, resistance, and their expression, indicating that it may be specific to ABCG2.  Analyses of its analogue compounds showed that the pharmacophore of PZ-39 is benzothiazole linked to a triazine ring backbone.  CONCLUSION/SIGNIFICANCE: Unlike any previously known ABCG2 transporter inhibitors, PZ-39 has a novel two-mode action by inhibiting ABCG2 activity, an acute effect, and by accelerating lysosome-dependent degradation, a chronic effect.  PZ-39 is potentially a valuable probe for structure-function studies of ABCG2 and a lead compound for developing therapeutics targeting ABCG2-mediated MDR in combinational cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC0xm59RfSIoJKJbLTgsvCfW6udTcc2eZq0Sa1vS5pm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MznvVCntw%253D%253D&md5=1643d34c5f91053aab0c4c5c2b18e9c1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0005676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0005676%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DA%2520Novel%2520Two%2520Mode-Acting%2520Inhibitor%2520of%2520ABCG2-Mediated%2520Multidrug%2520Transport%2520and%2520Resistance%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0005676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rehab  Sabour</span>, <span class="hlFld-ContribAuthor ">Marwa F.  Harras</span>, <span class="hlFld-ContribAuthor ">Omkulthom  Mohamed Al Kamaly</span>, <span class="hlFld-ContribAuthor ">Najla  Altwaijry</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (21)
                                     , 4892. <a href="https://doi.org/10.3390/molecules25214892" title="DOI URL">https://doi.org/10.3390/molecules25214892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25214892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25214892%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNovel%252B3-Cyanopyridines%252Bas%252BSurvivin%252BModulators%252Band%252BApoptosis%252BInducers%26aulast%3DSabour%26aufirst%3DRehab%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D21%26spage%3D4892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Analysis of LQZ-7 binding to survivin and synthesis of LQZ-7 analogues. (A) Molecular dynamic simulation analysis of LQZ-7 bound to the dimeric interface of survivin. (B) Critical interactions between LQZ-7 and survivin. (C) Scheme of LQZ-7 analogue (quinoxaline derivatives) synthesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Characterization of LQZ-7 analogues. (A, B) IC<sub>50</sub> of LQZ-7 and its analogues in C4-2 (A) and PC-3 (B) cells derived from dose–response survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S1</a>) as determined using methylene blue assay. (C, D) SEAP reporter activity determined using mammalian two hybrid assay in the presence of LQZ-7 or its analogues. Vector and p53/large T antigen were used as negative and positive controls for the assay, respectively (*<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Relative survivin protein level in different human prostate cancer cell lines determined using Western blot analyses. (B) IC<sub>50</sub> of <b>7I</b> in different human prostate cancer cell lines derived from dose-dependent survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S2</a>) as determined using methylene blue assay. (C) Association of <b>7I</b> IC<sub>50</sub> with survivin expression level in different human prostate cancer cell lines. (D, E) Expression of HA-tagged survivin determined using Western blot analysis (D) and IC<sub>50</sub> of <b>7I</b> derived from survival curves (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf" class="ext-link">Figure S3</a>) as determined using methylene blue assay (E) in stable C4-2 clone with overexpression of HA-tagged survivin (Sur) and vector-transfected (Vec) control cells. (***<i>p</i> < 0.001). (F) Effect of <b>7I</b> on the expression of survivin, XIAP, CIAP1, and CIAP2 in C4-2 and PC-3 cells as determined using Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>7I</b> induces survivin degradation in the proteasome. (A) Time course of <b>7I</b>-induced survivin loss in C4-2 and PC-3 cell lines determined using Western blot analysis. (B, C) Effect of <b>7I</b> on survivin half-life. C4-2 and PC-3 cells were pretreated with cycloheximide (CHX) followed by chasing for different times in the presence of <b>7I</b> or DMSO control. Cells were lysed for Western blot analysis of remaining survivin (B) and quantification of gel densities from three independent experiments (C). (D) Effect of proteasome inhibitors MG132 and bortezomib on <b>7I</b>-induced survivin degradation as determined using Western blot analysis. Actin was used as a loading control. Quantification was from three independent experiments (**<i>p</i> < 0.01; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>7I</b> induction of apoptosis. (A, B) Western blot analysis of cleaved caspase 3 in C4-2 (A) and PC-3 (B) cells following <b>7I</b> treatment. Quantifications were from three independent experiments. (C) Compound <b>7I</b>-induced apoptosis as determined using Annexin V staining in C4-2 and PC-3 cells (*<i>p</i> < 0.05; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/medium/jm0c00475_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>7I</b><i>in vivo</i> efficacy and target inhibition. (A, B) Effect of <b>7I</b> on ectopic xenograft tumor growth and body weight in male NSG mice. (■) <b>7I</b>; (●) vehicle. (C) Gross anatomy of xenograft tumors. (D) Final wet weight of xenograft tumors. (E, F) Western blot analysis of <i>in vivo</i> survivin target inhibition by <b>7I</b> treatment. (G) Immunofluorescence staining of survivin in xenograft tumors (*<i>p</i> < 0.05; ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00475/20200701/images/large/jm0c00475_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00475&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdecia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1038/76838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2F77929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10876248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslKnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=602-608&author=M.+A.+Verdeciaauthor=H.+Huangauthor=E.+Dutilauthor=D.+A.+Kaiserauthor=T.+Hunterauthor=J.+P.+Noel&title=Structure+of+the+human+anti-apoptotic+protein+survivin+reveals+a+dimeric+arrangement&doi=10.1038%2F76838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement</span></div><div class="casAuthors">Verdecia, Mark A.; Huang, Han-Kuei; Dutil, Erica; Kaiser, Donald A.; Hunter, Tony; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Survivin is a 16.5 kDa protein that is expressed during the G2/M phase of the cell cycle and is hypothesized to inhibit a default apoptotic cascade initiated in mitosis.  This inhibitory function is coupled to survivin's localization to the mitotic spindle.  To begin to address the structural basis of survivin's function, we report the x-ray crystal structure of a recombinant form of full length survivin to 2.58 Å resoln.  Survivin consists of two defined domains including an N-terminal Zn2+-binding BIR domain linked to a 65 Å amphipathic C-terminal α-helix.  The crystal structure reveals an extensive dimerization interface along a hydrophobic surface on the BIR domain of each survivin monomer.  A basic patch acting as a sulfate/phosphate-binding module, an acidic cluster projecting off the BIR domain, and a solvent-accessible hydrophobic surface residing on the C-terminal amphipathic helix, are suggestive of functional protein-protein interaction surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_Qka4OvVTrVg90H21EOLACvtfcHk0ljOtzkwyfvOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslKnurs%253D&md5=3af2584ef6f47edbd96d875b9789e878</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F77929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F77929%26sid%3Dliteratum%253Aachs%26aulast%3DVerdecia%26aufirst%3DM.%2BA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DDutil%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DD.%2BA.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructure%2520of%2520the%2520human%2520anti-apoptotic%2520protein%2520survivin%2520reveals%2520a%2520dimeric%2520arrangement%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D602%26epage%3D608%26doi%3D10.1038%2F76838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc-Brude, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brash, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchisio, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span> <span> </span><span class="NLM_article-title">Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1172/JCI13345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1172%2FJCI13345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11581300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Crsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=991-999&author=D.+Grossmanauthor=P.+J.+Kimauthor=O.+P.+Blanc-Brudeauthor=D.+E.+Brashauthor=S.+Togninauthor=P.+C.+Marchisioauthor=D.+C.+Altieri&title=Transgenic+expression+of+survivin+in+keratinocytes+counteracts+UVB-induced+apoptosis+and+cooperates+with+loss+of+p53&doi=10.1172%2FJCI13345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53</span></div><div class="casAuthors">Grossman, Douglas; Kim, Paul J.; Blanc-Brude, Olivier P.; Brash, Douglas E.; Tognin, Simona; Marchisio, Pier Carlo; Altieri, Dario C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">991-999</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis protein survivin has been implicated in both cell cycle control and apoptosis resistance.  To discriminate between these different roles, we used transgenic expression of survivin in the skin as a model for cell proliferation, differentiation, and apoptosis.  Transgenic mice expressing survivin under the control of a keratin-14 promoter developed normally, without histol. abnormalities of the skin or hair, epidermal hyperplasia, or developmental abnormalities of basal or suprabasal epidermis.  Keratinocyte proliferation assessed under basal conditions, or after UV-B (UVB) irradn., or phorbol ester stimulation was unchanged in survivin transgenic mice.  In contrast, survivin expression inhibited UVB-induced apoptosis in vitro and in vivo (i.e., sunburn cell formation), whereas it did not affect Fas-induced cell death.  When crossed with p53 knockout mice, transgenic expression of survivin in a p53+/- background substituted for the loss of a second p53 allele and further inhibited UVB-induced apoptosis.  These data provide the first in vivo evidence that survivin inhibits apoptosis and suggest that this pathway may oppose the elimination of cancerous cells by p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_r7Bt8tjTbLVg90H21EOLACvtfcHk0ljOtzkwyfvOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Crsrw%253D&md5=1947263b287c0ba7231b42741d41a3c6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1172%2FJCI13345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13345%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DP.%2BJ.%26aulast%3DBlanc-Brude%26aufirst%3DO.%2BP.%26aulast%3DBrash%26aufirst%3DD.%2BE.%26aulast%3DTognin%26aufirst%3DS.%26aulast%3DMarchisio%26aufirst%3DP.%2BC.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DTransgenic%2520expression%2520of%2520survivin%2520in%2520keratinocytes%2520counteracts%2520UVB-induced%2520apoptosis%2520and%2520cooperates%2520with%2520loss%2520of%2520p53%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D991%26epage%3D999%26doi%3D10.1172%2FJCI13345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: blocking the road to death’s door</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+blocking+the+road+to+death%E2%80%99s+door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0ljOtzkwyfvOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoufias, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, R. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(05)00020-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2FS1097-2765%2805%2900020-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10949039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls1KlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=183-189&author=L.+Chantalatauthor=D.+A.+Skoufiasauthor=J.+P.+Klemanauthor=B.+Jungauthor=O.+Didebergauthor=R.+L.+Margolis&title=Crystal+structure+of+human+survivin+reveals+a+bow+tie-shaped+dimer+with+two+unusual+alpha-helical+extensions&doi=10.1016%2FS1097-2765%2805%2900020-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual α-helical extensions</span></div><div class="casAuthors">Chantalat, Laurent; Skoufias, Dimitrios A.; Kleman, Jean-Philippe; Jung, Barbara; Dideberg, Otto; Margolis, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">183-189</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Survivin is a mitotic spindle-assocd. protein involved in linking mitotic spindle function to activation of apoptosis in mammalian cells.  The structure of the full-length human survivin has been detd. by x-ray crystallog. to 2.7 Å.  Strikingly, the structure forms a very unusual bow tie-shaped dimer.  It does not dimerize through a C-terminal coiled-coil, contrary to sequence anal. prediction.  The C-terminal helixes contain hydrophobic clusters with the potential for protein-protein interactions.  The unusual shape and dimensions of survivin suggest it serves an adaptor function through its α-helical extensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYbdoHgym3LVg90H21EOLACvtfcHk0lhDzEDCw5y-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls1KlsLs%253D&md5=6eeced36c940cb2a88acd83d7d86bf11</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900020-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900020-1%26sid%3Dliteratum%253Aachs%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DSkoufias%26aufirst%3DD.%2BA.%26aulast%3DKleman%26aufirst%3DJ.%2BP.%26aulast%3DJung%26aufirst%3DB.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DMargolis%26aufirst%3DR.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520human%2520survivin%2520reveals%2520a%2520bow%2520tie-shaped%2520dimer%2520with%2520two%2520unusual%2520alpha-helical%2520extensions%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D183%26epage%3D189%26doi%3D10.1016%2FS1097-2765%2805%2900020-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5315</span>– <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=9850056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5315-520&author=I.+Tammauthor=Y.+Wangauthor=E.+Sausvilleauthor=D.+A.+Scudieroauthor=N.+Vignaauthor=T.+Oltersdorfauthor=J.+C.+Reed&title=IAP-family+protein+survivin+inhibits+caspase+activity+and+apoptosis+induced+by+Fas+%28CD95%29%2C+Bax%2C+caspases%2C+and+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs</span></div><div class="casAuthors">Tamm, Ingo; Wang, Yan; Sausville, Ed; Scudiero, Dominic A.; Vigna, Nicole; Oltersdorf, Tilman; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5315-5320</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Survivin is a member of the inhibitor of apoptosis protein (IAP) family.  We investigated the antiapoptotic mechanism of Survivin, as well as its expression in 60 human tumor cell lines used for the National Cancer Institute's anti-cancer drug screening program.  In cotransfection expts., cell death induced by Bax or Fas (CD 95) was partially inhibited (mean ± SD, 65% ± 8%) by Survivin, whereas XIAP, another IAP family member, almost completely blocked cell death (93% ± 4%) under the same conditions.  Survivin and XIAP also protected 293 cells from apoptosis induced by overexpression of procaspase-3 and -7 and inhibited the processing of these zymogens into active caspases.  In vitro binding expts. indicated that, like other IAP-family proteins, Survivin binds specifically to the terminal effector cell death proteases, caspase-3 and -7, but not to the proximal initiator protease caspase-8.  Using a cell-free system in which cytosolic exts. were derived from control- or Survivin-transfected cells and where caspases were activated either by addn. of cytochrome c and dATP or by adding recombinant active caspase-8, Survivin was able to substantially reduce caspase activity, as measured by cleavage of a tetrapeptide substrate, AspGluValAsp-aminofluorocoumarin.  Similar results were obtained in intact cells when Survivin was overexpressed by gene transfection and caspase activation was induced by the anticancer drug etoposide.  Survivin was expressed in all 60 cancer cell lines analyzed, with highest levels in breast and lung cancers and lowest levels in renal cancers.  These findings indicate that Survivin, which is commonly expressed in human tumor cell lines, can bind the effector cell death proteases caspase-3 and -7 in vitro and inhibits caspase activity and cell death in cells exposed to diverse apoptotic stimuli.  Although quant. differences may exist, these observations suggest commonality in the mechanisms used by IAP-family proteins to suppress apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtAMNXwxGQWbVg90H21EOLACvtfcHk0lhDzEDCw5y-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSkt7w%253D&md5=32dd3234c150de44dce8ce501c6b0b65</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DVigna%26aufirst%3DN.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DIAP-family%2520protein%2520survivin%2520inhibits%2520caspase%2520activity%2520and%2520apoptosis%2520induced%2520by%2520Fas%2520%2528CD95%2529%252C%2520Bax%252C%2520caspases%252C%2520and%2520anticancer%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5315%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peereboom, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desideri, S.</span></span>; <span class="NLM_contrib-group">Adult Brain Tumor Consortium</span> <span> </span><span class="NLM_article-title">Phase I study of terameprocol in patients with recurrent high-grade glioma</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nor230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1093%2Fneuonc%2Fnor230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=22323663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=511-517&author=S.+A.+Grossmanauthor=X.+Yeauthor=D.+Peereboomauthor=M.+R.+Rosenfeldauthor=T.+Mikkelsenauthor=J.+G.+Supkoauthor=S.+Desideriauthor=Adult+Brain+Tumor+Consortium&title=Phase+I+study+of+terameprocol+in+patients+with+recurrent+high-grade+glioma&doi=10.1093%2Fneuonc%2Fnor230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of terameprocol in patients with recurrent high-grade glioma</span></div><div class="casAuthors">Grossman, Stuart A.; Ye, Xiaobu; Peereboom, David; Rosenfeld, Myrna R.; Mikkelsen, Tom; Supko, Jeffrey G.; Desideri, Serena</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Terameprocol is a global transcription inhibitor that affects cell division apoptosis, drug resistance, hypoxia responsive genes, and radiation resistance in hypoxia.  A multicenter, dose-escalation study was conducted in heavily pretreated patients with recurrent, measurable, high-grade gliomas.  Terameprocol was administered i.v. for 5 consecutive days each month and discontinued for toxicity or progression.  Patients taking enzyme-inducing antiseizure drugs (EIASDs) were escalated independently.  Thirty-five patients with a median Karnofsky performance status of 80, median age of 46 years, and median of 2 prior treatment regimens were accrued.  Doses of 750, 1100, 1700, and 2200 mg/day were administered.  Terameprocol was reformulated to avoid acidosis related to the excipient and was well tolerated at 1700 mg/day.  Hypoxia and interstitial nephritis were noted at 2200 mg/day.  Concurrent administration of EIASD did not significantly affect the serum pharmacokinetics of the terameprocol.  Although no responses were seen, stable disease was noted in 9 (28%) of 32 evaluable patients, with 5 (13%) continuing treatment for >6 mo (≥6, 8, 10, 10, and ≥21 mo).  The overall median survival was 5.9 mo.  This phase I study defined the toxicity of terameprocol, detd. that EIASDs do not affect its pharmacokinetics, and identified 1700 mg/day as the dose for future studies.  Preclin. and human data suggest that this novel transcription inhibitor is worthy of further study.  The long-term stability noted in some patients and the lack of assocd. myelosuppression suggest that terameprocol could be safely combined with radiation and temozolomide in newly diagnosed high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXUB0EBZG92LVg90H21EOLACvtfcHk0ljnjze-IzC0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hsLrF&md5=3c15db4347f37612b0c64749dab6b835</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor230%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DS.%2BA.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DPeereboom%26aufirst%3DD.%26aulast%3DRosenfeld%26aufirst%3DM.%2BR.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DDesideri%26aufirst%3DS.%26aulast%3D%26atitle%3DPhase%2520I%2520study%2520of%2520terameprocol%2520in%2520patients%2520with%2520recurrent%2520high-grade%2520glioma%26jtitle%3DNeuro%2520Oncol%26date%3D2012%26volume%3D14%26spage%3D511%26epage%3D517%26doi%3D10.1093%2Fneuonc%2Fnor230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, K.</span></span> <span> </span><span class="NLM_article-title">Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1353</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.onc.1203429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10713676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Krsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1346-1353&author=A.+Suzukiauthor=T.+Itoauthor=H.+Kawanoauthor=M.+Hayashidaauthor=Y.+Hayasakiauthor=Y.+Tsutomiauthor=K.+Akahaneauthor=T.+Nakanoauthor=M.+Miuraauthor=K.+Shiraki&title=Survivin+initiates+procaspase+3%2Fp21+complex+formation+as+a+result+of+interaction+with+Cdk4+to+resist+Fas-mediated+cell+death&doi=10.1038%2Fsj.onc.1203429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death</span></div><div class="casAuthors">Suzuki, Atsushi; Ito, Takeshi; Kawano, Hirokazu; Hayashida, Midori; Hayasaki, Yayoi; Tsutomi, Yumi; Akahane, Kouichi; Nakano, Takeshi; Miura, Masayuki; Shiraki, Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1346-1353</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase 3 is an essential death factor for the Fas-mediated cell death, and its inactivation in cells is initiated by an interaction with p21 on mitochondria or with IAP family member ILP.  Survivin is also a member of IAP family and is specifically expressed during embryogenesis and in tumor cells and suppresses cell death signaling.  In our current study, we demonstrated that Survivin translocation into the nucleus is dependent on Fas stimulation and cell proliferation.  Survivin also interacts with the cell cycle regulator Cdk4, leading to Cdk2/Cyclin E activation and Rb phosphorylation.  As a result of Survivin/Cdk4 complex formation, p21 is released from its complex with Cdk4 and interacts with mitochondrial procaspase 3 to suppress Fas-mediated cell death.  Here, we propose that Survivin supports procaspase 3/p21 complex formation as a result of interaction with Cdk4 resulting in suppression of cell death signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEBW9g8qAWLVg90H21EOLACvtfcHk0liUQNcFl4p6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Krsbc%253D&md5=77cb69bf5810f45ace180d5547e4f744</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203429%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawano%26aufirst%3DH.%26aulast%3DHayashida%26aufirst%3DM.%26aulast%3DHayasaki%26aufirst%3DY.%26aulast%3DTsutomi%26aufirst%3DY.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DShiraki%26aufirst%3DK.%26atitle%3DSurvivin%2520initiates%2520procaspase%25203%252Fp21%2520complex%2520formation%2520as%2520a%2520result%2520of%2520interaction%2520with%2520Cdk4%2520to%2520resist%2520Fas-mediated%2520cell%2520death%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D1346%26epage%3D1353%26doi%3D10.1038%2Fsj.onc.1203429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabenbauer, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, C.</span></span> <span> </span><span class="NLM_article-title">High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection</span>. <i>Strahlenther. Onkol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1007/s00066-002-1003-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1007%2Fs00066-002-1003-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12240548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BD38vnvVeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2002&pages=426-435&author=F.+Rodelauthor=J.+Hoffmannauthor=G.+G.+Grabenbauerauthor=T.+Papadopoulosauthor=C.+Weissauthor=K.+Guntherauthor=C.+Schickauthor=R.+Sauerauthor=C.+Rodel&title=High+survivin+expression+is+associated+with+reduced+apoptosis+in+rectal+cancer+and+may+predict+disease-free+survival+after+preoperative+radiochemotherapy+and+surgical+resection&doi=10.1007%2Fs00066-002-1003-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection</span></div><div class="casAuthors">Rodel Franz; Hoffmann Jorg; Grabenbauer Gerhard G; Papadopoulos Thomas; Weiss Christian; Gunther Klaus; Schick Christoph; Sauer Rolf; Rodel Claus</div><div class="citationInfo"><span class="NLM_cas:title">Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">426-35</span>
        ISSN:<span class="NLM_cas:issn">0179-7158</span>.
    </div><div class="casAbstract">BACKGROUND:  Spontaneous apoptosis has been shown to predict tumor response to preoperative radiochemotherapy in rectal cancer.  It remains to be elucidated, however, which genetic profile determines whether a tumor is more or less prone to apoptosis.  Recently, a novel member of the inhibitor of apoptosis family, designated survivin, was identified.  In the present study, we investigated the impact of survivin on tumor cell apoptosis and the risk to develop distant metastases or local failure after preoperative radiochemotherapy and surgical resection.  PATIENTS AND METHODS:  The expression of survivin, p53, bcl-2 and the apoptotic index was evaluated by immunohistochemistry on pretreatment biopsies of 54 patients with locally advanced adenocarcinoma of the rectum.  Survivin expression was correlated to clinical and histopathological markers, the levels of spontaneous apoptosis, p53 and bcl-2, as well as to disease-free survival, 5-year rates of local failure and distant disease after preoperative radiochemotherapy and surgical resection.  RESULTS:  Survivin expression inversely correlated with the apoptotic index: High survivin expression was found in 56% of rectal carcinoma biopsies with a median apoptotic index of 1.22%.  Conversely, low survivin expression in tumor cells was associated with a high median apoptotic index (2.29%, p = 0.0001).  High survivin expression also segregated with bcl-2 overexpression (65% bcl-2+ in tumors with high survivin expression as compared to 35% bcl-2+ in tumors with low survivin expression), but the difference was not statistically significant (p = 0.1).  Low survivin expression was significantly related to an increased disease-free survival rate (77% vs 18% at 5 years in tumors with high survivin expression, p = 0.02) and to a reduced risk for distant metastases (18% vs 78% at 5 years in tumors with high survivin expression, p = 0.05) and local failure (6% vs 37% at 5 years in tumors with high survivin expression, p = 0.07).  CONCLUSION:  An inverse correlation between survivin expression and the level of spontaneous apoptosis in pretreatment biopsies suggests that survivin strongly inhibits tumor cell apoptosis in rectal cancer.  Survivin expression may provide a novel predictive indicator for disease-free survival after preoperative radiochemotherapy and surgical resection in rectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp6eZYIX2HUXWEEzDrymxmfW6udTcc2ea5HhJvn-hCG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vnvVeltw%253D%253D&md5=369e1bac65190da60abc2c29fe4c407a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00066-002-1003-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00066-002-1003-y%26sid%3Dliteratum%253Aachs%26aulast%3DRodel%26aufirst%3DF.%26aulast%3DHoffmann%26aufirst%3DJ.%26aulast%3DGrabenbauer%26aufirst%3DG.%2BG.%26aulast%3DPapadopoulos%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DC.%26aulast%3DGunther%26aufirst%3DK.%26aulast%3DSchick%26aufirst%3DC.%26aulast%3DSauer%26aufirst%3DR.%26aulast%3DRodel%26aufirst%3DC.%26atitle%3DHigh%2520survivin%2520expression%2520is%2520associated%2520with%2520reduced%2520apoptosis%2520in%2520rectal%2520cancer%2520and%2520may%2520predict%2520disease-free%2520survival%2520after%2520preoperative%2520radiochemotherapy%2520and%2520surgical%2520resection%26jtitle%3DStrahlenther.%2520Onkol.%26date%3D2002%26volume%3D178%26spage%3D426%26epage%3D435%26doi%3D10.1007%2Fs00066-002-1003-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weck, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunebach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossart, P.</span></span> <span> </span><span class="NLM_article-title">Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-08-2554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1182%2Fblood-2002-08-2554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12576330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=571-576&author=S.+M.+Schmidtauthor=K.+Schagauthor=M.+R.+Mullerauthor=M.+M.+Weckauthor=S.+Appelauthor=L.+Kanzauthor=F.+Grunebachauthor=P.+Brossart&title=Survivin+is+a+shared+tumor-associated+antigen+expressed+in+a+broad+variety+of+malignancies+and+recognized+by+specific+cytotoxic+T+cells&doi=10.1182%2Fblood-2002-08-2554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells</span></div><div class="casAuthors">Schmidt, Susanne M.; Schag, Kerstin; Mueller, Martin R.; Weck, Markus M.; Appel, Silke; Kanz, Lothar; Gruenebach, Frank; Brossart, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Survivin, a member of the inhibitor of apoptosis protein family, is expressed in almost all types of malignancies, making this protein a useful tool for the development of broadly applicable vaccination therapies.  The authors used a recently identified HLA-A2 binding peptide and dendritic cells (DCs) from healthy donors to induce survivin-specific cytotoxic T lymphocytes (CTLs) in vitro.  These T cells efficiently lysed target cells pulsed with the cognate peptide.  Furthermore, survivin-specific CTLs recognized HLA-A2-matched tumor cell lines and primary malignant cells from patients with leukemia in an antigen-specific and HLA-restricted manner as demonstrated with the use of cold target inhibition assays and blocking antibodies.  To validate the immunogenicity of survivin the authors performed the expts. in an autologous setting and used monocyte-derived DCs as targets.  Interestingly, the authors found that DCs up-regulate survivin expression on stimulation with tumor necrosis factor α (TNF-α).  However, these mature DCs were not recognized by survivin-specific CTLs, whereas they lysed autologous mature DCs pulsed with the antigenic peptide or transfected with whole tumor RNA purified from a survivin-expressing cell line.  To further analyze the possible use of survivin-specific CTLs in cancer therapies, the authors induced survivin-specific CTLs using peripheral blood mononuclear cells (PBMNCs) and DCs from a patient with chronic lymphocytic leukemia (CLL).  The in vitro-generated T cells efficiently recognized autologous malignant CLL cells, whereas they spared autologous-purified non-malignant B cells or DCs.  The results demonstrate that survivin epitopes are presented on a broad variety of malignancies and can be applied in vaccination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpcS3EEmOWLVg90H21EOLACvtfcHk0liae7eVjsl6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGitL4%253D&md5=0387ca794904d4a52453cfd5d2a6e758</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-08-2554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-08-2554%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%2BM.%26aulast%3DSchag%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DM.%2BR.%26aulast%3DWeck%26aufirst%3DM.%2BM.%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DKanz%26aufirst%3DL.%26aulast%3DGrunebach%26aufirst%3DF.%26aulast%3DBrossart%26aufirst%3DP.%26atitle%3DSurvivin%2520is%2520a%2520shared%2520tumor-associated%2520antigen%2520expressed%2520in%2520a%2520broad%2520variety%2520of%2520malignancies%2520and%2520recognized%2520by%2520specific%2520cytotoxic%2520T%2520cells%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D571%26epage%3D576%26doi%3D10.1182%2Fblood-2002-08-2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothermel, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plescia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchisio, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic cell-division defects and apoptosis induced by interference with survivin function</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1038/70242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2F70242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10587640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK1MXotFaltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=461-466&author=F.+Liauthor=E.+J.+Ackermannauthor=C.+F.+Bennettauthor=A.+L.+Rothermelauthor=J.+Plesciaauthor=S.+Togninauthor=A.+Villaauthor=P.+C.+Marchisioauthor=D.+C.+Altieri&title=Pleiotropic+cell-division+defects+and+apoptosis+induced+by+interference+with+survivin+function&doi=10.1038%2F70242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic cell-division defects and apoptosis induced by interference with survivin function</span></div><div class="casAuthors">Li, Fengzhi; Ackermann, Elizabeth J.; Bennett, C. Frank; Rothermel, Annette L.; Plescia, Janet; Tognin, Simona; Villa, Antonello; Marchisio, Pier Carlo; Altieri, Dario C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">461-466</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">Here we investigate the role of the control of apoptosis in normal cell division.  We show that interference with the expression or function of the apoptosis inhibitor survivin causes caspase-dependent cell death in the G2/M phase of the cell cycle, and a cell-division defect characterized by centrosome dysregulation, multipolar mitotic spindles and multinucleated, polyploid cells.  Use of a dominant-neg. survivin mutant or antisense survivin complementary DNA disrupts a supramol. assembly of survivin, caspase-3 and the cyclin-dependent-kinase inhibitor p21Waf1/Clp1 within centrosomes, and results in caspase-dependent cleavage of p21.  Polyploidy induced by survivin antagonists is accentuated in p21-deficient cells, and cor. by exogenous expression of p21.  These findings show that control of apoptosis and preservation of p21 integrity within centrosomes by survivin are required for normal mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLUS45BjrfRLVg90H21EOLACvtfcHk0liae7eVjsl6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFaltbo%253D&md5=33245c413e04f44f57097965e3e5eb67</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F70242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F70242%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAckermann%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DC.%2BF.%26aulast%3DRothermel%26aufirst%3DA.%2BL.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DTognin%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DMarchisio%26aufirst%3DP.%2BC.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DPleiotropic%2520cell-division%2520defects%2520and%2520apoptosis%2520induced%2520by%2520interference%2520with%2520survivin%2520function%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26spage%3D461%26epage%3D466%26doi%3D10.1038%2F70242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeger, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowsert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1038/sj.neo.7900091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.neo.7900091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10935509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=235-241&author=J.+Chenauthor=W.+Wuauthor=S.+K.+Tahirauthor=P.+E.+Kroegerauthor=S.+H.+Rosenbergauthor=L.+M.+Cowsertauthor=F.+Bennettauthor=S.+Krajewskiauthor=M.+Krajewskaauthor=K.+Welshauthor=J.+C.+Reedauthor=S.+C.+Ng&title=Down-regulation+of+survivin+by+antisense+oligonucleotides+increases+apoptosis%2C+inhibits+cytokinesis+and+anchorage-independent+growth&doi=10.1038%2Fsj.neo.7900091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth</span></div><div class="casAuthors">Chen, Jun; Wu, Wei; Tahir, Stephen K.; Kroeger, Paul E.; Rosenberg, Saul H.; Cowsert, Lex M.; Bennett, Frank; Krajewski, Stanislaw; Krajewska, Maryla; Welsh, Kate; Reed, John C.; Ng, Shi-Chung</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-241</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Survivin, a member of the inhibitor of apoptosis protein (IAP) family, is detected in most common human cancers but not in adjacent normal cells.  Previous studies suggest that survivin assocs. with the mitotic spindle and directly inhibits caspase activity.  To further investigate the function of survivin, we used a survivin antisense (AS) oligonucleotide to down-regulate survivin expression in normal and cancer cells.  We found that inhibition of survivin expression increased apoptosis and polyploidy while decreasing colony formation in soft agar.  Immunohistochem. showed that cells without survivin can initiate the cleavage furrow and contractile ring, but cannot complete cytokinesis, thus resulting in multinucleated cells.  These findings indicate that survivin plays important roles in a late stage of cytokinesis, as well as in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69BGMgkWGlbVg90H21EOLACvtfcHk0liae7eVjsl6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGhtLs%253D&md5=10260ead64e27ad7c9e8ccfd9aafd13b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.neo.7900091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.neo.7900091%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DKroeger%26aufirst%3DP.%2BE.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DCowsert%26aufirst%3DL.%2BM.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DKrajewska%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DS.%2BC.%26atitle%3DDown-regulation%2520of%2520survivin%2520by%2520antisense%2520oligonucleotides%2520increases%2520apoptosis%252C%2520inhibits%2520cytokinesis%2520and%2520anchorage-independent%2520growth%26jtitle%3DNeoplasia%26date%3D2000%26volume%3D2%26spage%3D235%26epage%3D241%26doi%3D10.1038%2Fsj.neo.7900091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasof, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B. C.</span></span> <span> </span><span class="NLM_article-title">Livin, a novel inhibitor of apoptosis protein family member</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">3238</span>– <span class="NLM_lpage">3246</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003670200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1074%2Fjbc.M003670200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11024045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3238-3246&author=G.+M.+Kasofauthor=B.+C.+Gomes&title=Livin%2C+a+novel+inhibitor+of+apoptosis+protein+family+member&doi=10.1074%2Fjbc.M003670200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Livin, a novel inhibitor of apoptosis protein family member</span></div><div class="casAuthors">Kasof, Gary M.; Gomes, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3238-3246</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A novel human inhibitor of apoptosis protein (IAP) family member termed Livin was identified, contg. a single baculoviral IAP repeat (BIR) domain and a C-terminal RING finger domain.  The mRNA for livin was not detectable by Northern blot in most normal adult tissues with the exception of the placenta, but was present in developmental tissues and in several cancer cell lines.  Highest levels were obsd. in two melanoma-derived cell lines, G361 and SK-Mel29.  Transfection of livin in HeLa cells resulted in protection from apoptosis induced by expression of FADD, Bax, RIP, RIP3, and DR6.  Similar to other IAP family members, the anti-apoptotic activity of Livin was dependent on the BIR domain.  Livin was also capable of inhibiting DEVD-like caspase activity triggered by tumor necrosis factor-α.  In vitro binding studies demonstrated a direct interaction between Livin and the active form of the downstream caspases, caspase-3 and -7, that was dependent on the BIR domain of Livin.  In addn., the unprocessed and cleaved forms of caspase-9 co-immunopptd. with Livin in vivo, and recombinant Livin could inhibit the activation of caspase-9 induced by Apaf-1, cytochrome c, and dATP.  The subcellular distribution of the transfected Livin was analyzed by immunofluorescence.  Both Livin and Survivin were expressed in the nucleus and in a filamentous pattern throughout the cytoplasm.  In contrast to the apoptotic activity, the C-terminal RING domain mediated its subcellular localization patterning.  Further studies found that transfection of an antisense construct against livin could trigger apoptosis specifically in cell lines expressing livin mRNA.  This was assocd. with an increase in DNA fragmentation and in DEVD-like caspase activity.  Thus, disruption of Livin may provide a strategy to induce apoptosis in certain cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtwzmTk4KEirVg90H21EOLACvtfcHk0lhdxzwyJROMdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFWjurg%253D&md5=23e8d7bcdfbc69cb0fa2fad22f6720b0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003670200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003670200%26sid%3Dliteratum%253Aachs%26aulast%3DKasof%26aufirst%3DG.%2BM.%26aulast%3DGomes%26aufirst%3DB.%2BC.%26atitle%3DLivin%252C%2520a%2520novel%2520inhibitor%2520of%2520apoptosis%2520protein%2520family%2520member%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3238%26epage%3D3246%26doi%3D10.1074%2Fjbc.M003670200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olie, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes-Wust, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leech, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangemeister-Wittke, U.</span></span> <span> </span><span class="NLM_article-title">A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10850418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFOlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2805-2809&author=R.+A.+Olieauthor=A.+P.+Simoes-Wustauthor=B.+Baumannauthor=S.+H.+Leechauthor=D.+Fabbroauthor=R.+A.+Stahelauthor=U.+Zangemeister-Wittke&title=A+novel+antisense+oligonucleotide+targeting+survivin+expression+induces+apoptosis+and+sensitizes+lung+cancer+cells+to+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy</span></div><div class="casAuthors">Olie, Robert A.; Simoes-Wust, A. Paula; Baumann, Bettina; Leech, Sian H.; Fabbro, Doriano; Stahel, Rolf A.; Zangemeister-Wittke, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2805-2809</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Survivin, an inhibitor of apoptosis protein, deserves attention as a selective target for cancer therapy because it lacks expression in differentiated adult tissues but is expressed in a variety of human tumors.  The authors designed 20-mer phosphorothioate antisense oligonucleotides targeting different regions of survivin mRNA and investigated their ability to down-regulate survivin mRNA and induce apoptosis in the lung adenocarcinoma cell line A549.  Oligonucleotide 4003, which targets nucleotides 232-251 of survivin mRNA, was identified as the most potent compd.  As measured by real-time PCR, 4003 down-regulated survivin mRNA in a dose-dependent manner with an IC50 of 200 nM.  Its max. effect was achieved at a concn. of 400 nM, at which mRNA was down-regulated by 70%.  As revealed by increased caspase-3-like protease activity, nuclear condensation and fragmentation, and trypan blue uptake, treatment with 4003 induced apoptosis and sensitized tumor cells to the chemotherapeutic agent etoposide.  Oligonucleotide 4003 did not reduce the viability of normal blood leukocytes with marginal levels of survivin mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeR2m75LCs1rVg90H21EOLACvtfcHk0lhdxzwyJROMdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFOlsLo%253D&md5=470bc41be64009b9ef134d44d8ad5ab2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlie%26aufirst%3DR.%2BA.%26aulast%3DSimoes-Wust%26aufirst%3DA.%2BP.%26aulast%3DBaumann%26aufirst%3DB.%26aulast%3DLeech%26aufirst%3DS.%2BH.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DStahel%26aufirst%3DR.%2BA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DA%2520novel%2520antisense%2520oligonucleotide%2520targeting%2520survivin%2520expression%2520induces%2520apoptosis%2520and%2520sensitizes%2520lung%2520cancer%2520cells%2520to%2520chemotherapy%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2805%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daidone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span> <span> </span><span class="NLM_article-title">Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1172/JCI0214891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1172%2FJCI0214891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=11805141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=285-286&author=M.+Pennatiauthor=G.+Colellaauthor=M.+Foliniauthor=L.+Cittiauthor=M.+G.+Daidoneauthor=N.+Zaffaroni&title=Ribozyme-mediated+attenuation+of+survivin+expression+sensitizes+human+melanoma+cells+to+cisplatin-induced+apoptosis&doi=10.1172%2FJCI0214891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis</span></div><div class="casAuthors">Pennati, Marzia; Colella, Gennaro; Folini, Marco; Citti, Lorenzo; Daidone, Maria Grazia; Zaffaroni, Nadia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-286</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The hammerhead ribozymes targeting the 3' end of the CUA110and the GUC294 (RZ7) triplets in the survivin mRNA were developed as an alternative strategy for survivin inhibition.  To assess the effect of survivin inhibition on the susceptibility of melanoma cells to undergo cisplatin-induced apoptosis, three stably transfected clones, RZ1/C, RZ7/H and mutRZ1/B, were treated with 10 μg/mL of the drug for 1 h.  The presence of apoptotic nuclei in cells stained with propidium iodide under fluorescence microscopy was also detd. at 72 h after treatment.  A considerable increase in the percentage of apoptotic cells was obsd. in RZ1/C and RZ7/H cells, while a very moderate apoptotic response was detected in mutRZ1/B.  The attenuation of survivin expression in the melanoma cell system was insufficient to significantly trigger apoptosis in the absence of other stimuli.  However, the attenuation of survivin expression made the melanoma cells more susceptible to cisplatin-induced apoptosis.  These findings indicated the possible strategy to enhance the chemosensitivity profile of such a drug-refractory human malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwXy-wrux7Vg90H21EOLACvtfcHk0li1PtS7zxEtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVKruw%253D%253D&md5=e5b6eafd6beb5f45cc4881885f647dbc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1172%2FJCI0214891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0214891%26sid%3Dliteratum%253Aachs%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DColella%26aufirst%3DG.%26aulast%3DFolini%26aufirst%3DM.%26aulast%3DCitti%26aufirst%3DL.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DZaffaroni%26aufirst%3DN.%26atitle%3DRibozyme-mediated%2520attenuation%2520of%2520survivin%2520expression%2520sensitizes%2520human%2520melanoma%2520cells%2520to%2520cisplatin-induced%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D285%26epage%3D286%26doi%3D10.1172%2FJCI0214891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaynor, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scoggin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokaslan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becerra, C.</span></span> <span> </span><span class="NLM_article-title">Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12631590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFKiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=931-46&author=N.+S.+Williamsauthor=R.+B.+Gaynorauthor=S.+Scogginauthor=U.+Vermaauthor=T.+Gokaslanauthor=C.+Simmangauthor=J.+Flemingauthor=D.+Tavanaauthor=E.+Frenkelauthor=C.+Becerra&title=Identification+and+validation+of+genes+involved+in+the+pathogenesis+of+colorectal+cancer+using+cDNA+microarrays+and+RNA+interference"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference</span></div><div class="casAuthors">Williams, Noelle Sevilir; Gaynor, Richard B.; Scoggin, Shane; Verma, Udit; Gokaslan, Tunc; Simmang, Clifford; Fleming, Jason; Tavana, Denise; Frenkel, Eugene; Becerra, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">931-946</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to profile gene expression changes in colorectal tumors to identify new targets and strategies for the management of this disease.  cDNA microarray anal. was used to detect differences in gene expression between normal tissue and colon tumors and polyps isolated from 20 patients.  To identify genes that are important in regulating the growth properties of colorectal cancer, RNA interference (RNAi) was used to disrupt expression of several of the overexpressed genes in a colon tumor cell line, HCT116, which showed similar patterns of gene expression as many of the patient tumors.  Expression changes of ≥2-fold in approx. one-third of the patients were consistently obsd. for 2632 of a total of 9592 genes (574 up-regulated genes and 2058 down-regulated genes).  Subsequent anal. of 13 genes by quant. real-time PCR confirmed the reliability of this anal.  RNAi-mediated disruption of the expression of one of these genes, survivin, a potent inhibitor of apoptosis, severely reduced tumor growth both in vitro and in an in vivo xenograft model.  The combined use of microarray anal. and RNAi provides an excellent system to define the role of specific genes that are up-regulated in cancer lead to the increased in vitro and in vivo growth of colon tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMJuqOrM-ibVg90H21EOLACvtfcHk0li1PtS7zxEtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFKiurs%253D&md5=71c20301c117690baec91c5c9c00f558</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DGaynor%26aufirst%3DR.%2BB.%26aulast%3DScoggin%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DU.%26aulast%3DGokaslan%26aufirst%3DT.%26aulast%3DSimmang%26aufirst%3DC.%26aulast%3DFleming%26aufirst%3DJ.%26aulast%3DTavana%26aufirst%3DD.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DBecerra%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520validation%2520of%2520genes%2520involved%2520in%2520the%2520pathogenesis%2520of%2520colorectal%2520cancer%2520using%2520cDNA%2520microarrays%2520and%2520RNA%2520interference%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D931%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. H.</span></span> <span> </span><span class="NLM_article-title">Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells</span>. <i>Cancer Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1038/sj.cgt.7700531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1038%2Fsj.cgt.7700531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=12536196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1ymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=87-95&author=K.+S.+Choiauthor=T.+H.+Leeauthor=M.+H.+Jung&title=Ribozyme-mediated+cleavage+of+the+human+survivin+mRNA+and+inhibition+of+antiapoptotic+function+of+survivin+in+MCF-7+cells&doi=10.1038%2Fsj.cgt.7700531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells</span></div><div class="casAuthors">Choi, Kyoung Suk; Lee, Tae Ho; Jung, Myeong Ho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Survivin is a new member of the inhibitor of apoptosis protein (IAP) family that is implicated in the control of cell proliferation and the regulation of cell life span.  This protein is selectively expressed in most human carcinomas but not in normal adult tissues.  To down-regulate a human survivin expression as a strategy for cancer gene therapy, we designed two hammerhead ribozymes (RZ-1, RZ-2) targeting human survivin mRNA.  RZ-1 and RZ-2 efficiently cleaved the human survivin mRNA at nucleotide positions +279 and +289, which was identified by in vitro cleavage assay using in vitro transcribed ribozymes and truncated survivin mRNA substrate.  To investigate the function of the ribozymes in cells, the sequences of the ribozymes were cloned into replication-deficient adenoviral vector and transferred to breast cancer cell, MCF-7.  The infection with adenovirus encoding the ribozymes resulted in a significant redn. of survivin mRNA (74% and 73%, resp.) and protein.  As revealed by nuclear condensation/ fragmentation and flow cytometry anal., inhibition of survivin gene by ribozymes increased apoptosis and sensitivity induced by etoposide or serum starvation.  Our results suggest that the designed hammerhead ribozymes against survivin mRNA are good candidates for feasible gene therapy in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPfmfMBCgloLVg90H21EOLACvtfcHk0lgx4YafqpXpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1ymtg%253D%253D&md5=659a930f7e7075a9771868718ceedd6c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700531%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DK.%2BS.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DJung%26aufirst%3DM.%2BH.%26atitle%3DRibozyme-mediated%2520cleavage%2520of%2520the%2520human%2520survivin%2520mRNA%2520and%2520inhibition%2520of%2520antiapoptotic%2520function%2520of%2520survivin%2520in%2520MCF-7%2520cells%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D87%26epage%3D95%26doi%3D10.1038%2Fsj.cgt.7700531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting survivin for therapeutic discovery: past, present, and future promises</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2Fj.drudis.2017.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=28577912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1466-1477&author=R.+C.+Peeryauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Targeting+survivin+for+therapeutic+discovery%3A+past%2C+present%2C+and+future+promises&doi=10.1016%2Fj.drudis.2017.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting survivin for therapeutic discovery: past, present, and future promises</span></div><div class="casAuthors">Peery, Robert C.; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1466-1477</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is overexpressed in cells of almost all cancers but not in most normal tissues in adults.  Survivin expression is required for cancer cell survival and knocking down its expression or inhibiting its function using mol. approaches results in spontaneous apoptosis.  Thus, survivin is an attractive and perhaps ideal target for cancer drug discovery.  However, a US Food and Drug Administration (FDA)-approved drug targeting survivin has yet to emerge.  In this Foundation Review, we examine and evaluate various strategies that have been used to target survivin and the stages of each survivin inhibitor to help understand this lack of success.  We also provide future perspectives moving forward in targeting survivin for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjdIclTWikbVg90H21EOLACvtfcHk0lgx4YafqpXpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D&md5=e0c67912f0c8fbd96ba9bd3d454dc879</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520survivin%2520for%2520therapeutic%2520discovery%253A%2520past%252C%2520present%252C%2520and%2520future%2520promises%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26spage%3D1466%26epage%3D1477%26doi%3D10.1016%2Fj.drudis.2017.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aljahdali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">368</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1362-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1186%2Fs13046-019-1362-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=31439015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgsF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=368&author=F.+Liauthor=I.+Aljahdaliauthor=X.+Ling&title=Cancer+therapeutics+using+survivin+BIRC5+as+a+target%3A+what+can+we+do+after+over+two+decades+of+study%3F&doi=10.1186%2Fs13046-019-1362-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?</span></div><div class="casAuthors">Li Fengzhi; Aljahdali Ieman; Ling Xiang; Li Fengzhi; Aljahdali Ieman; Ling Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Survivin (also named BIRC5) is a well-known cancer therapeutic target.  Since its discovery more than two decades ago, the use of survivin as a target for cancer therapeutics has remained a central goal of survivin studies in the cancer field.  Many studies have provided intriguing insight into survivin's functional role in cancers, thus providing promise for survivin as a cancer therapeutic target.  Despite this, moving survivin-targeting agents into and through the clinic remains a challenge.  In order to address this challenge, we may need to rethink current strategies in order to develop a new mindset for targeting survivin.  In this Review, we will first summarize the current survivin mechanistic studies, and then review the status of survivin cancer therapeutics, which is classified into five categories: (i) survivin-partner protein interaction inhibitors, (ii) survivin homodimerization inhibitors, (iii) survivin gene transcription inhibitors, (iv) survivin mRNA inhibitors and (v) survivin immunotherapy.  We will then provide our opinions on cancer therapeutics using survivin as a target, with the goal of stimulating discussion that might facilitate translational research for discovering improved strategies and/or more effective anticancer agents that target survivin for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMtQEKH7hnxdts4TFFB11gfW6udTcc2eYU_fGJ1ieg5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgsF2hsA%253D%253D&md5=98ff4475bb1640831f1c42b398b4519c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1362-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1362-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAljahdali%26aufirst%3DI.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DCancer%2520therapeutics%2520using%2520survivin%2520BIRC5%2520as%2520a%2520target%253A%2520what%2520can%2520we%2520do%2520after%2520over%2520two%2520decades%2520of%2520study%253F%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D368%26doi%3D10.1186%2Fs13046-019-1362-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Effective targeting of the survivin dimerization interface with small-molecule inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1158%2F0008-5472.CAN-15-1874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=26744521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1WisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=453-62&author=J.+Qiauthor=Z.+Dongauthor=J.+Liuauthor=R.+C.+Peeryauthor=S.+Zhangauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Effective+targeting+of+the+survivin+dimerization+interface+with+small-molecule+inhibitors&doi=10.1158%2F0008-5472.CAN-15-1874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors</span></div><div class="casAuthors">Qi, Jing; Dong, Zizheng; Liu, Jianguo; Peery, Robert C.; Zhang, Shaobo; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-462</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Many oncoproteins are considered undruggable because they lack enzymic activities.  In this study, we present a small-mol.-based anticancer agent that acts by inhibiting dimerization of the oncoprotein survivin, thereby promoting its degrdn. along with spontaneous apoptosis in cancer cells.  Through a combination of computational anal. of the dimerization interface and in silico screening, we identified one compd. that induced proteasome-dependent survivin degrdn.  Anal. of a set of structural analogs led us to identify a lead compd. (LQZ-7F), which was effective in blocking the survival of multiple cancer cell lines in a low micromolar concn. range.  LQZ-7F induced proteasome-dependent survivin degrdn., mitotic arrest, and apoptosis, and it blocked the growth of human tumors in mouse xenograft assays.  In addn. to providing preclin. proof of concept for a survivin-targeting anticancer agent, our work offers novel in silico screening strategies to therapeutically target homodimeric oncogenic proteins considered undruggable.  Cancer Res; 76(2); 453-62. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFIaf1nDDoJbVg90H21EOLACvtfcHk0lgvv21IbSjTtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1WisA%253D%253D&md5=b8ca613a6f9c029097942e21dc212025</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1874%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DEffective%2520targeting%2520of%2520the%2520survivin%2520dimerization%2520interface%2520with%2520small-molecule%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D453%26epage%3D62%26doi%3D10.1158%2F0008-5472.CAN-15-1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zietman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1002/pros.20263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1002%2Fpros.20263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=15754318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=293-302&author=M.+Zhangauthor=N.+Mukherjeeauthor=R.+S.+Bermudezauthor=D.+E.+Lathamauthor=M.+A.+Delaneyauthor=A.+L.+Zietmanauthor=W.+U.+Shipleyauthor=A.+Chakravarti&title=Adenovirus-mediated+inhibition+of+survivin+expression+sensitizes+human+prostate+cancer+cells+to+paclitaxel+in+vitro+and+in+vivo&doi=10.1002%2Fpros.20263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo</span></div><div class="casAuthors">Zhang, Min; Mukherjee, Neelanjan; Bermudez, R. Scott; Latham, Douglas E.; Delaney, Meaghan A.; Zietman, Anthony L.; Shipley, William U.; Chakravarti, Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Improvements in the response rates to chemotherapy would represent an important advancement in the care of patients with metastatic prostate cancer.  There is accumulating evidence that Survivin, a member of the inhibitor of apoptosis (IAP) family, is assocd. with both cancer progression and drug resistance.  The purpose of this study is to investigate the role of Survivin in paclitaxel-resistance and whether the targeting of Survivin sensitizes prostate cancer cells to paclitaxel.  Human prostate cell lines PC-3, DU-145, and LNCaP were infected with replication-deficient adenoviruses encoding either wild-type Survivin [pAd-S(WT)], to examine Survivin overexpression effects, or a phosphorylation-defective Survivin Thr34→Ala dominant neg. mutant [pAd-S(T34A)], to examine Survivin inactivation effects.  The effects of wild-type or mutant Survivin on spontaneous and paclitaxel-induced apoptosis were investigated both in vitro and in vivo.  Forced overexpression of wild-type Survivin with pAd-S(WT) increased resistance to paclitaxel in all cell lines, both in vitro and in vivo.  Inhibition of Survivin using pAd-S(T34A) resulted in a significant increase in the rate of spontaneous and paclitaxel-induced apoptosis in all cell lines, both in vitro and in vivo.  This effect was abolished by co-treatment with VAD-CHO (Calbiochem, San Diego, CA), a pan-caspase inhibitor, indicating that Survivin normally mediates resistance to paclitaxel through suppression of caspase-mediated apoptosis.  Survivin mediates paclitaxel-resistance in prostate cancer cells.  The inhibition of Survivin sensitizes prostate cancer cells to paclitaxel-induced apoptosis through a caspase-dependant mechanism in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn-rqmz_5WLVg90H21EOLACvtfcHk0lgvv21IbSjTtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFSmtL0%253D&md5=150623b791c6eef14e8093a2d0f31b20</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fpros.20263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.20263%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DN.%26aulast%3DBermudez%26aufirst%3DR.%2BS.%26aulast%3DLatham%26aufirst%3DD.%2BE.%26aulast%3DDelaney%26aufirst%3DM.%2BA.%26aulast%3DZietman%26aufirst%3DA.%2BL.%26aulast%3DShipley%26aufirst%3DW.%2BU.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DAdenovirus-mediated%2520inhibition%2520of%2520survivin%2520expression%2520sensitizes%2520human%2520prostate%2520cancer%2520cells%2520to%2520paclitaxel%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProstate%26date%3D2005%26volume%3D64%26spage%3D293%26epage%3D302%26doi%3D10.1002%2Fpros.20263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(94)90522-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1016%2FS0092-8674%2894%2990522-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=8087847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1994&pages=799-811&author=R.+Faganauthor=K.+J.+Flintauthor=N.+Jones&title=Phosphorylation+of+E2F-1+modulates+its+interaction+with+the+retinoblastoma+gene+product+and+the+adenoviral+E4+19+kDa+protein&doi=10.1016%2FS0092-8674%2894%2990522-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein</span></div><div class="casAuthors">Fagan, Rick; Flint, Kate J.; Jones, Nic</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The transcription factor E2F is regulated through its cyclical interaction with a spectrum of cellular proteins.  One such protein is the product of the retinoblastoma gene (Rb); assocn. of E2F with Rb inhibits its transactivation potential.  However, in adenovirus-infected cells, E2F is complexed to the 19 kDa product of the adenovirus E4 gene.  The authors have studied the interaction of E2F-1 with the Rb and adenovirus E4 proteins and show that phosphorylation of E2F-1 on serine residues 332 and 337 prevented its interaction with Rb but was a prerequisite for interaction with E4.  These residues were phosphorylated in vivo and by p34cdc2 kinase in vitro.  Upon stimulation of serum-starved cells, phosphorylation was induced in the late G1 phase of the cell cycle.  These observations suggest that phosphorylation of E2F-1 is important in the regulation of its activity during the cell cycle and during infection of cells by adenovirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR2N66oy36GrVg90H21EOLACvtfcHk0liFEuVKj3ZmtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVaitr8%253D&md5=fe0ad781e738fb267fcc8d5ed2a2c7f9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2894%2990522-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252894%252990522-3%26sid%3Dliteratum%253Aachs%26aulast%3DFagan%26aufirst%3DR.%26aulast%3DFlint%26aufirst%3DK.%2BJ.%26aulast%3DJones%26aufirst%3DN.%26atitle%3DPhosphorylation%2520of%2520E2F-1%2520modulates%2520its%2520interaction%2520with%2520the%2520retinoblastoma%2520gene%2520product%2520and%2520the%2520adenoviral%2520E4%252019%2520kDa%2520protein%26jtitle%3DCell%26date%3D1994%26volume%3D78%26spage%3D799%26epage%3D811%26doi%3D10.1016%2FS0092-8674%2894%2990522-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, C.</span></span> <span> </span><span class="NLM_article-title">Chiasmal and Retrochiasmal Disorders</span>. <i>Int. Ophthalmol. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1097/IIO.0000000000000280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1097%2FIIO.0000000000000280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=31233416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MzgtFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=59-81&author=J.+D.+Beebeauthor=M.+S.+Leeauthor=C.+McClelland&title=Chiasmal+and+Retrochiasmal+Disorders&doi=10.1097%2FIIO.0000000000000280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chiasmal and Retrochiasmal Disorders</span></div><div class="casAuthors">Beebe Johanna D; Lee Michael S; McClelland Collin</div><div class="citationInfo"><span class="NLM_cas:title">International ophthalmology clinics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">59-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYSRsLU9l2_oqdXsLcGTEUfW6udTcc2ea3tePEhLMQ37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzgtFKitg%253D%253D&md5=b49473461251cc9445f878cfa0c5e879</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1097%2FIIO.0000000000000280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FIIO.0000000000000280%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMcClelland%26aufirst%3DC.%26atitle%3DChiasmal%2520and%2520Retrochiasmal%2520Disorders%26jtitle%3DInt.%2520Ophthalmol.%2520Clin.%26date%3D2019%26volume%3D59%26spage%3D59%26epage%3D81%26doi%3D10.1097%2FIIO.0000000000000280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e5676</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0005676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=10.1371%2Fjournal.pone.0005676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=19479068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;key=1%3ACAS%3A280%3ADC%252BD1MznvVCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=H.+Pengauthor=Z.+Dongauthor=J.+Qiauthor=Y.+Yangauthor=Y.+Liuauthor=Z.+Liauthor=J.+Xuauthor=J.+T.+Zhang&title=A+Novel+Two+Mode-Acting+Inhibitor+of+ABCG2-Mediated+Multidrug+Transport+and+Resistance+in+Cancer+Chemotherapy&doi=10.1371%2Fjournal.pone.0005676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy</span></div><div class="casAuthors">Peng Hui; Dong Zizheng; Qi Jing; Yang Youyun; Liu Yang; Li Zhaomin; Xu Junkang; Zhang Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e5676</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND: Multidrug resistance (MDR) is a major problem in successful treatment of cancers.  Human ABCG2, a member of the ATP-binding cassette transporter superfamily, plays a key role in MDR and an important role in protecting cancer stem cells.  Knockout of ABCG2 had no apparent adverse effect on the mice.  Thus, ABCG2 is an ideal target for development of chemo-sensitizing agents for better treatment of drug resistant cancers and helping eradicate cancer stem cells.  METHODS/PRELIMINARY FINDINGS: Using rational screening of representatives from a chemical compound library, we found a novel inhibitor of ABCG2, PZ-39 (N-(4-chlorophenyl)-2-[(6-{[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-yl)sulfanyl]acetamide), that has two modes of actions by inhibiting ABCG2 activity and by accelerating its lysosome-dependent degradation.  PZ-39 has no effect on ABCB1 and ABCC1-mediated drug efflux, resistance, and their expression, indicating that it may be specific to ABCG2.  Analyses of its analogue compounds showed that the pharmacophore of PZ-39 is benzothiazole linked to a triazine ring backbone.  CONCLUSION/SIGNIFICANCE: Unlike any previously known ABCG2 transporter inhibitors, PZ-39 has a novel two-mode action by inhibiting ABCG2 activity, an acute effect, and by accelerating lysosome-dependent degradation, a chronic effect.  PZ-39 is potentially a valuable probe for structure-function studies of ABCG2 and a lead compound for developing therapeutics targeting ABCG2-mediated MDR in combinational cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC0xm59RfSIoJKJbLTgsvCfW6udTcc2ea3tePEhLMQ37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MznvVCntw%253D%253D&md5=1643d34c5f91053aab0c4c5c2b18e9c1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0005676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0005676%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DA%2520Novel%2520Two%2520Mode-Acting%2520Inhibitor%2520of%2520ABCG2-Mediated%2520Multidrug%2520Transport%2520and%2520Resistance%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0005676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00475">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82235"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00475?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00475</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Dose–response curves for all compounds for survival of human prostate cancer cell lines C4-2 and PC-3 and for <b>7I</b> for cell lines DU145, PC-3, C4-2, 22RV-1, and LNCaP and C4-2 stably overexpressing survivin, mean wet weight of major organs in <b>7I</b> treated mice, and purity analysis of <b>7I</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_001.pdf">jm0c00475_si_001.pdf (267.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00475/suppl_file/jm0c00475_si_002.csv">jm0c00475_si_002.csv (0.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00475&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00475%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00475" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f4733ff03291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
